09.07.2015 Views

M E S '9 8 - University of Georgia College of Veterinary Medicine

M E S '9 8 - University of Georgia College of Veterinary Medicine

M E S '9 8 - University of Georgia College of Veterinary Medicine

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

VM E S ‘98<strong>Veterinary</strong> Medical Experiment Station<strong>College</strong> <strong>of</strong> <strong>Veterinary</strong> <strong>Medicine</strong>The <strong>University</strong> <strong>of</strong> <strong>Georgia</strong>Athens, <strong>Georgia</strong> 30602July 1, 1997 to June 30, 199822nd Annual ReportEnhancing animal production, pr<strong>of</strong>itability, and well-being by improving animal health.This 22nd Annual Report is published by the <strong>Veterinary</strong> Medical Experiment Station, The <strong>University</strong> <strong>of</strong> <strong>Georgia</strong>.Director: Dr. Harry W. DickersonManaging Editor: Mary HooperWriter and Associate Editor: Robin TricolesDesigners: Jimmy Davidson and Lari CowgillCover Design: Lari Cowgill and Kip CarterIllustrator: Kip CarterPhotographers: Vivian Dixon and Joey RodgersThis report may be viewed in Adobe Acrobat form at www.vet.uga.edu/testbed/html/vmes98.pdf


VMES ObjectivesOver the years, the <strong>Veterinary</strong> MedicalExperiment Station has supported a widerange <strong>of</strong> research projects touching almostevery critical aspect <strong>of</strong> human life, fromthe food we eat and the clothes we wear toour physical, emotional, and economichealth and the quality <strong>of</strong> our environment.This tradition continues as is evident in thepr<strong>of</strong>iles <strong>of</strong> 1997-98 research described inthis report. The past year’s projectsencompass efforts aimed at improving productivityand health <strong>of</strong> poultry and livestock,bettering life’s quality for companionanimals, and tackling tough interdisciplinaryproblems in biotechnology anddisease surveillance.Prior to their initiation, each <strong>of</strong> theseprojects was evaluated for scientific merit,importance to animal health, considerationfor experimental animal welfare, and rolein meeting the research objectives <strong>of</strong> the<strong>Veterinary</strong> Medical Experiment Station.These objectives are the following:To improve the health and productivity<strong>of</strong> domestic livestock, poultry, fish, andother income-producing animals andwildlife through research.To assist in preventing diseaseepidemics by providing laboratoryresources and highly skilled scientificpersonnel.To assist in protecting human healththrough the control <strong>of</strong> animal diseasestransmissible to man.To improve the health <strong>of</strong> companion animalswhich serve to enrich the lives <strong>of</strong>humankind.To train new scientists in animal healthresearch in order to provide continuityand growth in this area <strong>of</strong> veterinarymedicine.2


DNA VaccinesEver since Dr. Edward Jenner’s famous experiment in 1796, which introducedvaccination as a preventive measure against small pox, doctors have been using vaccinationto prevent many diseases in humans and animals. Conventional vaccines consist <strong>of</strong>the disease agent that has been killed or modified so it no longer can cause disease.When the vaccine is administered, the body recognizes it as a foreign substance and animmune response, which protects the individual from that specific disease, is induced. Ifthe disease agent is encountered again, antibodies and lymphocytes (immune cells)attack and kill it.After an immune response is induced as a result <strong>of</strong> a natural infection orvaccination, the body typically makes antibodies and lymphocytes against proteins thatmake up the disease agent. In general, the flow <strong>of</strong> molecules at the cellular level is DNAto RNA to protein. The genetic information contained in the DNA is transferred toRNA, which is used by the cell machinery to synthesize proteins, which are the buildingblocks <strong>of</strong> the cell or disease agent. So, each protein that makes up the disease agent hasa corresponding gene (segment <strong>of</strong> DNA). Using molecular biology,we can extract DNA from a disease agent and isolate the gene thatcontains the information for the protein that induces a protectiveimmune response.DNA vaccines are genes from a disease agent that areinjected directly into the body. The cells <strong>of</strong> the body take up theDNA, and proteins are synthesized through the natural flow <strong>of</strong> moleculesin the cell (DNA to RNA to proteins). Because those proteinsresemble the proteins that make up the disease agent, they arerecognized as foreign by the body, and an immune response isinduced. This is the basis behind DNA vaccination.A tremendous amount <strong>of</strong> research has been conducted onDNA vaccines, and the future <strong>of</strong> DNA immunization appears verybright. DNA vaccines have been shown to be safe and extremelyeffective for a wide variety <strong>of</strong> disease agents.Dr. Mark Jackwood, Associate Pr<strong>of</strong>essor at the PoultryDiagnostic and Disease Laboratory, analyzing nucleicacid data.DEFGCBADNA (B) is extracted from the disease agent (A) and made into a DNA vaccine (C). The DNA vaccine is injected intramuscularly (D)into a chicken, which produces sensitized macrophages (E). These sensitized macrophages communicate their information to immunecells (F), which produce antibodies (G). The antibodies, in conjunction with immune cells, destroy the disease agent.5


Poultry<strong>Georgia</strong>’s poultry industry dominated the state’s animal agricultural dollars withmore than $2.5 billion in annual revenue in 1996. The state’s poultry industry iscontinuing to expand as broiler production in <strong>Georgia</strong> increased from 20.6million per week in 1995 to 22.2 million per week in 1996. The urbanization <strong>of</strong>northern <strong>Georgia</strong> is causing the broiler expansion to occur primarily in the state’ssouthern section. Because <strong>of</strong> the intensive management system, poultryproducers emphasize disease prevention. VMES scientists have responded toindustry demands by developing vaccines to prevent infectious diseases. Theyare also helping to improve poultry health by developing inexpensive, rapid, andaccurate methods for disease diagnosis. Although the primary poultry healthconcerns are respiratory diseases, recent efforts have been initiated to controltype J avian leukosis virus, a major cause <strong>of</strong> the tumor, myeloblastosis.Researchers are also focusing on the reduction <strong>of</strong> potential human pathogens onpoultry products nationwide.Increasing Resistance to Marek’s Diseasevia Immune ModulationDiagnostics for Avian Enteric CoronavirusInfections in Commercial Poultry6The overall objectives <strong>of</strong> this project are toestablish the importance <strong>of</strong> natural killer (NK)cell-like activity in the innate ability <strong>of</strong> chickensto resist Marek’s disease virus (MDV)infection and to then determine whether modulation<strong>of</strong> this natural immunity (NK cell activity)could be used as part <strong>of</strong> Marek’s diseaseprevention programs.We have assessed NK-like activity <strong>of</strong>chickens having haplotypes reported to confereither resistance, N-2a chickens (B13), or sensitivity,P-2a chickens (B21), to MDV. Theresults from cytotoxicity assays indicate N-2achickens have greater killing capabilities byNK cells than the P-2a chickens. The N-2achickens displayed greater killing at one, two,and three weeks <strong>of</strong> age, with the increasebecoming significant by the third week. Wehave also compared NK activities in two commerciallines <strong>of</strong> broilers: Arbor Acres line andPerdue line. Between these two broiler lineswe found the Perdue birds to have significantlyhigher natural cytotoxic ability. Studies wereperformed to assess the efficacy <strong>of</strong> possibleimmune modulators on susceptibility toMarek’s disease. NK cell activity was assayedat day 7 postvirus challenge (day 14 postmodulation).Surviving birds were euthanized, andnecropsy with histopathology was performedat six weeks for determination <strong>of</strong> disease susceptibility,organ involvement, and severity <strong>of</strong>disease. In the broiler line (Arbor Acres), theimmunomodulator significantly increased theNK-like cytotoxic activity. Comparison <strong>of</strong>immunomodulated birds with birds thatreceived only virus suggests that theimmunomodulator may be a protective factoragainst Marek’s disease in this broiler line.Denise I. Bounous, Steven E. Poet, William L.Ragland, Mark A. Goodwindbounous@calc.vet.uga.eduVirus neutralizing polyclonal antibodieswere developed in rabbits using multipleimmunizations <strong>of</strong> adjuvant plus purified cellculture-origin sucrose gradient purified avianenteric coronavirus (AEC). The antibodieswere used to develop 1) an indirect immun<strong>of</strong>luorescentantibody detection system (IFA)for either AEC or anti-AEC antibody afterinfection; 2) fluorescent detection <strong>of</strong> AEC infrozen tissue sections; and 3) immunohistochemicaldetection <strong>of</strong> AEC in formalin-fixedtissue sections. The IFA system was adapted to96 well microtiter plates to increase throughput.The latter antibody technique is currentlybeing used as part <strong>of</strong> the eradication plan todetect flocks naturally infected with AEC, sothey can be eliminated to prevent spread toother poultry farms. Bovine enteric coronaviruswas found to infect commercial turkeys.Infection <strong>of</strong> poultry with this virus leads toconfusion in AEC eradication programs. Wehave developed seven monoclonal antibodies(Mabs) against AEC surface proteins. TheseMabs are being used in the IFA test to differentiateAEC infection from bovine coronavirus(BCV) infection in cell cultures and birds.Genes coding for the S surface viral protein<strong>of</strong> multiple AEC isolates have beensequenced and primer sets constructed to identifythese genes. Polymerase chain reaction(PCR) assays have been developed based onthese primers. These PCR primers and additionalprimer sets are currently being investigatedfor in situ use as probes for AEC. Inaddition, sequences coding for AEC viral proteinS are being cloned into vectors for production<strong>of</strong> vaccinal quantities <strong>of</strong> this viral proteinfor test immunization.Thomas P. Brown, Doris D’Souza, Laura Kelly,AnaPatricia Garciatbrown@arches.uga.edu


Differential Diagnosis <strong>of</strong> InfectiousLaryngotracheitis Viruses by PCRInfectious Laryngotracheitis is a severeacute respiratory disease <strong>of</strong> chickens caused byInfectious Laryngotracheitis Virus (ILTV), amember <strong>of</strong> the family Alphaherpesviridiae.During 1994-1995, ILT outbreaks were reportedin <strong>Georgia</strong>, Alabama, Arkansas, andDelaware. These outbreaks caused severefinancial losses to the poultry industry. Themajor obstacle against the effective control andprevention <strong>of</strong> the disease is the inability toclearly and easily determine the source <strong>of</strong> outbreaks.Therefore, discrimination <strong>of</strong> ILTVstrains <strong>of</strong> different pathogenicity, and particularly<strong>of</strong> field isolates from vaccine strains, is amajor necessity. The main objective <strong>of</strong> thisproject is to develop a polymerase chain reaction(PCR) test capable <strong>of</strong> distinguishingamong ILTV strains circulating in the field.We have identified restriction enzyme site differencesin the gE gene, and the upstreamregion <strong>of</strong> the ICP4 gene. Digestion <strong>of</strong> PCRproducts with specific enzymes, deduced fromthe sequence data obtained during this year’sproject, has allowed us to characterize fieldisolates as either “chicken embryo origin(CEO) like,” or “tissue culture origin (TCO)like” vaccine strains. Most importantly, wehave identified restriction enzymes that producerestriction fragment length polymorphism(RFLP) patterns unique to some <strong>of</strong> the fieldisolates analyzed. These indicate that specificmutations are acquired by field isolates atthese particular areas <strong>of</strong> the genome, for example,digestion <strong>of</strong> PCR products <strong>of</strong> the sevenfield isolates with enzymes DdeI, MnLI,and Ple.Maricarmen Garcíamcgarcia@arches.uga.eduprocess <strong>of</strong> producing a recombinant chickenbeta-defensin.Recombinant peptides will be used tocharacterize the complete spectrum <strong>of</strong> antimicrobialactivity against avian pathogens.Moreover, development <strong>of</strong> resistance to theseendogenous antibiotics by pathogenic bacteriacan be studied using recombinant defensins.Ultimately, it may be possible to manipulatethis endogenous defense system to enhancedisease resistance in poultry.Barry G. Harmon and Mark W. Jackwoodharmonb@calc.vet.uga.eduRecombinant Vaccines for InfectiousBronchitis VirusThe main objective <strong>of</strong> this proposal is todevelop a recombinant vaccine for infectiousbronchitis virus (IBV). A plasmid expressionvector that works in an avian cell line is beingused to express the immunogenic spike glycoprotein<strong>of</strong> IBV. The expressed protein is beingcharacterized and tested for its suitability as asubunit vaccine in chickens. In addition, anewly redesigned nucleic acid vaccine for IBV,which provides higher expression <strong>of</strong> the IBVspike glycoprotein, was tested and found to beefficacious when given to young chickens byintramuscular injection at 1 and 14 days <strong>of</strong>age. We are currently examining the immuneresponse generated by that vaccine, as well astesting for its suitability when given in ovo.Mark W. Jackwoodmjackwoo@arches.uga.eduAntimicrobial Peptides in Broiler ChickensAntimicrobial peptides are important components<strong>of</strong> innate disease resistance in vertebrateand invertebrate animals. These peptidesarm phagocytic leukocytes and mucosalepithelial cells <strong>of</strong> the gastrointestinal and respiratorytract with a broad spectrum <strong>of</strong> antimicrobialactivity and serve as the first line <strong>of</strong>defense against microbial pathogens. Recently,we discovered the cDNA sequences for twochicken and two turkey heterophil antimicrobialpeptides, referred to as betadefensins.We will now attempt to sequencethe genes that encode the avian defensins andthen study the regulation and expression <strong>of</strong>these genes. We have cloned the cDNAsequences for a chicken peptide and are in theVictoria Leiting works on DNA fingerprinting <strong>of</strong> Mycoplasma organisms.7


8Avian MycoplasmosisThe avian mycoplasmas,Mycoplasma gallisepticum(MG) and Mycoplasma.synoviae (MS) occur as eggtransmittedinfections causingrespiratory, joint, and tendondisease in chickens andturkeys. The objectives <strong>of</strong> thisstudy were to improve detectionand control measures foravian mycoplasma infection,to study pathogenesis, and todetermine the incidence <strong>of</strong>avian mycoplasmas by DNA“fingerprinting.” A polymerasechain reaction (PCR)with random primers(RAPD), developed for rapididentification <strong>of</strong> specificstrains <strong>of</strong> MG and other avianmycoplasmas is now routinelyused to identify (fingerprint)specific strains andidentify sources <strong>of</strong> infection.A library <strong>of</strong> avian mycoplasmaisolates containing severalDr. Susan Sanchez perpares an ELISA test tohundred isolates has provento be very useful in studyingdetect Pasteurella multocida.strain variation. In addition,PCR primers that detect allknown mycoplasmas, followed by cutting thePCR product with specific enzymes, were utilizedto identify specific strains <strong>of</strong> MG. MGstrains could be categorized into at least sixgroups by this method. This may provide amethod <strong>of</strong> “fingerprinting” that would notrequire prior isolation <strong>of</strong> the organism, whichis <strong>of</strong>ten very difficult and might take up tothree weeks.MG vaccine strain ts-11, previouslyshown by us to be effective in multiple agecommercial egg operations for MG control anderadication, has been studied in broiler breeders.This strain was very effective in the field,and measurable protection continued for thelife <strong>of</strong> the flock. MG, which is pathogenic forchickens and turkeys, is widespread in wildhouse finches and now seems to be on thedecline. Few new cases were identified. Amodel for consistent reproduction <strong>of</strong> clinicalsynovitis with field strains <strong>of</strong> MS was developed.This method will prove useful in studiesevaluating antibiotic medication and/or vaccination.In collaboration with Dr. DusanBencina at the <strong>University</strong> <strong>of</strong> Ljubljana inSlovenia, the hemagglutinin (HA) <strong>of</strong> MS wasidentified as a virulence factor. HA positiveclones were pathogenic, whereas HA negativestrains were not. These results improve ourability to detect and control MG and othermycoplasmas in commercial poultry.Stanley H. Kleven, Willie D. Hall, MarcusHead, Kathy Turner, and Victoria Leitingskleven@arches.uga.eduNeuraminidase is a Conserved Antigen <strong>of</strong>Pasteurella multocida“Sometimes there breaks out in the poultry-yarda disastrous disease, commonlyknown as chicken cholera. The animal whichis prey to this infection is without strength,trembles and has drooping wings.” LouisPasteur spoke these words in 1880 when herevealed his fowl cholera vaccine to the ParisAcademy <strong>of</strong> Sciences. Pasteur, now known asthe father <strong>of</strong> modern microbiology, developedthe first attenuated-live vaccine effectiveagainst infection. Live vaccine strains are stillused today to prevent fowl cholera. However,the available live vaccine strains are <strong>of</strong>ten toopathogenic for use in chickens, and killed vaccinesinduce protection only against closelyrelated strains <strong>of</strong> Pasteurella multocida, thebacterium responsible for the disease. We proposeto create a recombinant vaccine that willinduce protection against all P. multocidastrains. We have cloned and sequenced a genepresent in all strains <strong>of</strong> P. multocida.Furthermore, we have protected chickens fromfowl cholera using recombinant protein fromthis gene. The long-term goal <strong>of</strong> our researchis to create an effective broadly protective vaccineagainst fowl cholera that can be inexpensivelyused by <strong>Georgia</strong> poultry producers.Margie D. Leeleem@calc.vet.uga.eduThe Distribution <strong>of</strong> Virulence Specific-Genesamong Avian Escherichia coli IsolatesAlthough usually commensal residents inmammals and birds, a small percentage <strong>of</strong>Escherichia coli isolates can cause disease intheir hosts. Virulence <strong>of</strong> any microbe is dependenton the organism’s genetics. We haveexamined the distribution <strong>of</strong> specific virulencegenes among avian E. coli encountered innorthern <strong>Georgia</strong>. Genes encoding forhemolysins and toxins were absent in avian E.coli as determined from either polymerasechain reaction (PCR) or Southern blots. Othergenes, such as the capsule gene kps and sialicacid-binding lectin sfa, are present in avian E.coli but at a low frequency. Emphasis has beenplaced on looking at the distribution <strong>of</strong> P-fimbrialgenes among avian E. coli. We lookedspecifically at the adhesin protein <strong>of</strong> the P-pili,PapG. This protein determines specificity <strong>of</strong>disaccharides recognized by the pili. Inuropathogenic E. coli, there are three PapGalleles, PapG J96 , PapG Ia , and PrsG, that recognizethree different galactosyl disaccharidespresent on the glyolipids <strong>of</strong> red blood cells.The PapG allele, PapG Ia, is the only adhesinthat has been identified in avian E. coli byeither PCR or Southern blot. This gene waspresent in 25% <strong>of</strong> the E. coli isolatesexamined.


Hemolysin is one type <strong>of</strong> virulence factorthat assists in the pathogenesis <strong>of</strong> E. coli.Currently, hemolytic activity in E. coli hasbeen attributed to one <strong>of</strong> two alpha hemolysingenes found in either uropathogenic <strong>of</strong> enterohemorrhagicE. coli. Hemolytic avian E. coliisolates, however, lack both these E. colihemolysin genes. A “new” E. coli gene, hylE,was identified which lacked the conservedamino acid sequence and accessory genescommon to alpha hemolysin. The hlyE genewas found to map at position on the E. colichromosome where virulence genes are commonlyfound in uropathogenic E. coli. Incloning another E. coli hemolysin gene, an E.coli gene was identified that was similar to aSalmonella virulence gene. We are currentlyinvestigating the distribution <strong>of</strong> this “new”gene among E. coli pathogenic for poultry.Characterization <strong>of</strong> these virulence genes willassist in our development <strong>of</strong> probes and crossprotectivevaccines against avian E. coli.John J. Maurerjmaurer@arches.uga.eduInvestigation <strong>of</strong> Hatchery DisinfectantEfficacy and Effect on Broiler ProductionHatchery sanitation has a significantimpact on chick quality. The proper use <strong>of</strong> disinfectantsis essential. A disinfectant with greatpromise as a hatchery sanitizer due to its lowcost, efficacy, and low level <strong>of</strong> toxicity ishydrogen peroxide. Aerosol bacterial counts,egg moisture loss, hatchability, chick quality,and broiler productivity were measured in eggsexposed to hydrogen peroxide fogging andcompared with eggs not exposed to disinfectantduring the incubation period. The efficacy<strong>of</strong> hydrogen peroxide was also evaluated in thepresence <strong>of</strong> severe challenge withStaphylococcus aureus contaminated eggs.There was a significant reduction in aerosolbacterial counts within the hatcher when incubatorswere fogged with 3% hydrogen peroxidewhen compared with water-foggedmachines, even in the face <strong>of</strong> high bacterialchallenge. Eggs exposed to hydrogen peroxidelost a significantly greater amount <strong>of</strong> moistureduring incubation, but hatchability was notaffected. The use <strong>of</strong> hydrogen peroxide as ahatchery sanitizer did not affect broiler livability,body weight, or feed conversion but didreduce the incidence <strong>of</strong> retained yolk sacs in42-day old chickens.Jean E. Sander and Jeanna L. Wilsonjsander@arches.uga.eduIncorporation <strong>of</strong> Computer-AssistedLearning in Poultry Disease TrainingThe poultry industry in the United Statesis a $40 billion industry, which requires theattention <strong>of</strong> qualified experts in the field <strong>of</strong>poultry health. An explosion <strong>of</strong> knowledge isoccurring in veterinary and agricultural sciences.The study <strong>of</strong> poultry health is highlyspecialized with a few select students enteringthe field. Because the majority <strong>of</strong> students leanin other directions, many veterinary and agriculturalcurriculums are unable to maintainpoultry health courses. A computerized autotutoriallearning system for the study <strong>of</strong> poultrydiseases is being developed to fill this educationalvoid. The main objective <strong>of</strong> this computerprogram is to support the teaching <strong>of</strong>anatomy and pathology <strong>of</strong> different poultryspecies. The disease topics are presented byorgan system and etiology. Basic informationsuch as a glossary, detailed postmortem directions,description <strong>of</strong> the types <strong>of</strong> poultry, andinformation on husbandry practices such asbiosecurity is <strong>of</strong>fered to the student to accommodateevery level <strong>of</strong> knowledge. The format<strong>of</strong> the program uses the Internet throughNetscape with only local use allowed. Linksare provided within the program to allow thestudent to access a selected topic for study, orthe student can proceed through the programfrom beginning to end. Images are incorporatedin the text to allow the student to see thelesions associated with each disease.Jean E. Sanderjsander@arches.uga.eduInvestigation <strong>of</strong> Natural Disease Outbreaksand Field Trial StudiesRespiratory diseasewas investigated in onebroiler operation. Viralserology, isolation, andpolymerase chain reaction(PCR) were used to identifythe primary agent as infectiousbronchitis. Secondarybacterial infection withBordetella avium,Escherichia coli, andOrnithobacteriumrhinotracheale (ORT) wasconfirmed by bacterial culture<strong>of</strong> tracheal swabs.Modification <strong>of</strong> the vaccinationprogram helped toalleviate the problem.Aspergillus fumigatuswas isolated from youngchicks with early mortalityand respiratory problems.Recommendations from ourclinical veterinarians helpedthe integrator to bring theproblem under control.Hemagglutination-inhibition(HI) serology, virusisolation, and PCR testsrevealed that Arkansas 99strain <strong>of</strong> infectious bronchitisvirus was the cause <strong>of</strong> aDr. Jean Sander performs a preliminary examination<strong>of</strong> day-old chickens prior to microbiological tests.9


10respiratory problem in a broiler operation.Modification <strong>of</strong> the vaccination programbrought the problem under control. The estimatedannual saving is more than $100,000.The PCR technique has permitted generation<strong>of</strong> more useful and timely informationthan classical diagnostic techniques for infectiousbronchitis and mycoplasmas. Researchcontinues and new PCR tests will be applied todiagnostics as applications are developed.Diagnostic Services Laboratory activity isrepresented by 5,107 accessions, 20,481 bacterialprocedures, 979 antimicrobial susceptibilities,56,832 enzyme-linked immunoadsorbentassay (ELISA), 17,632 infectious bronchitishemagglutination-inhibition (IBV-HI) tests,22,000 histopathology slides, 248 diagnosticPCR tests, and 579 necropsies.Stephan G. Thayer, R. Kenny Page, George N.Rowland, Thomas P. Brown, Jean E. Sander,John R. Glisson, Stanley H. Kleven, PedroVillegas, Stanley A. Vezeysthayer@arches.uga.eduIsolation, Identification, and Control <strong>of</strong>Avian VirusesSeveral molecular techniques, includingpolymerase chain reaction (PCR), reverse transcriptase-polymerasechain reaction (RT-PCR),restriction fragment length polymorphism(RFLP), and in situ hybridization, were used toanalyze important sequences <strong>of</strong> the nucleicacid <strong>of</strong> field strains <strong>of</strong> infectious bursal diseasevirus (IBDV). One strain from <strong>Georgia</strong> wassimilar in sequence to Delaware E variantstrain, a second strain was similar to the GLSstrain also reported from the Delmarva area,and a third strain was similar to the pathogenicclassic standard strain. The results obtainedwere similar with all the molecular techniquesevaluated. Analysis <strong>of</strong> portions <strong>of</strong> the viralDr. Pedro Villegas examines a tissue culture for lesions associated with infection<strong>of</strong> avian viruses.nucleic acid indicated that the genetic variationobserved among the IBDV isolates are due tonatural genetic drift rather than to selectivepressures.Four pathogenic adenoviruses isolatedfrom field cases associated with inclusion bodyhepatitis were classified as group E adenovirus,using restriction patterns <strong>of</strong> extractedviral DNA generated by the restriction endonucleasesBamHI and HindIII. These results confirmedthe pathogenicity <strong>of</strong> the isolates.A rapid method to identify strains <strong>of</strong>infectious bronchitis virus (IBV) has beendeveloped. Using neuraminidase to treat theallantoic fluid obtained from chicken embryos,a hemagglutination reaction indicates the presence<strong>of</strong> the IBV. The method had a 98% correlationwhen compared with RT-PCR, which isconsiderably more expensive.Pedro VillegasPedrov@arches.uga.eduLarge Molecular Weight Plasmid Role inthe Pathogenesis <strong>of</strong> Avian E. coliFinancial losses due to colibacillosis costthe poultry industry hundreds <strong>of</strong> millions <strong>of</strong>dollars annually. Virulence traits <strong>of</strong> bacterialorganisms are encoded by specific genes locatedon the bacterial chromosome or on largemolecular weight (MW) plasmids. Escherichiacoli strain V-1 (V-1 wt ) is a well characterized,pathogenic avian strain isolated from a broilerchicken with colisepticemia, which containsseveral plasmids, two <strong>of</strong> which are high MWplasmids.We are looking for a genetic marker (designatedepv) that indicates the putative virulencegene located on the virulence plasmid,pWT3 (<strong>of</strong> E. coli strain V-1), and we want todetermine what this virulence factor contributesto the mechanism <strong>of</strong> pathogenicity inavian disease. The organisms to be testedinclude E. coli strain V-1 wt , E. coli strain V-1 wt restored with the virulence gene, andappropriate positive and negative controls. Theability <strong>of</strong> the organisms to kill chicken embryonatedeggs will be used as a measure <strong>of</strong> virulencefor the organisms tested. Twelve-day-oldchicken embryos will be inoculated withapproximately 10 2 colony forming units(CFUs) <strong>of</strong> the appropriate isolate, which isdeposited into the allantoic fluid. In anotherprocedure, 10 2 CFUs will be inoculated intothe yolk sac <strong>of</strong> six-day-old embryos. Embryoswill be candled daily. The number <strong>of</strong> deathswill be recorded, and tissues will be taken forreisolation and histopathology. Previous statisticalanalysis has shown us the EmbryoLethality Assay performed with 20 embryos/group repeated at least three times is sufficientsampling for statistical analysis. Once the epvgene is delineated, we want to compare themechanism(s) <strong>of</strong> pathogenicity between thewild-type organism and the wild-type organ-


ism without the epv gene. The results <strong>of</strong> theembryo lethality will then be used to decidethe challenge model for adult chickens t<strong>of</strong>urther the understanding <strong>of</strong> the virulencemechanism(s) associated with pWT3 <strong>of</strong> E. colistrain V-1 wt .Richard E. Wooley, Penelope S. Gibbs ,andThomas P. Brownrwooley@calc.vet.uga.eduEvaluation <strong>of</strong> Mechanism <strong>of</strong> Tendon Failurein Heavy Meat Type BirdsIn heavy meat type birds, lack <strong>of</strong> tendonintegrity and associated lameness are poorlyunderstood. The specific role <strong>of</strong> growth rate,management practices, and strain <strong>of</strong> bird in thegenesis <strong>of</strong> the problem is not clear. Tendonsmay fail with no apparent lesion to explaincause. A procedure to detect alteration in fibrillarcollagen type would help define a prefailurechange in tendon quality. Utilization <strong>of</strong> monoclonalantibodies to procollagen type I and collagentype III in an immunodection procedurehas been developed to show differentialresponses <strong>of</strong> avian tendon to heat, exercise,and rupture. Eighteen day-old embryonic tendonexplants grown at 43 o C had decreasedprocollagen and expression. Treadmill exercisefor four weeks increased procollagen collagenwith no change in collagen III. In ruptured tendons,the staining in tendon fibers was diminishedfor both procollagen I and collagen III.The peritenon and epitenon, however, hadincreased reactivity to both collagen typesindicative <strong>of</strong> prior injury to the tendons.Changes in level <strong>of</strong> expression <strong>of</strong> collagen typecorrelated with changes in the regulatory proteinsTGF B messenger RNA.Dr. George N. Rowlandgrowland@arches.uga.eduDr. George Rowland prepares tissue sections <strong>of</strong> avian tendon to aid in detemining why thesetissues fail in heavy meat birds.11


Fish<strong>Georgia</strong>’s aquaculture industry continues to expand with its greatest increase inchannel catfish. Since 1995, pond acreage for catfish farming has grown from6,000 to 8,000 acres. Major areas <strong>of</strong> disease concern continue to be losses causedby channel catfish virus and the bacteria Flavobacterium columnare andEdwardsiella ictaluri. Furthermore, there have been extensive losses in <strong>Georgia</strong>this spring because <strong>of</strong> the protozoan parasite Ichthyophthirius multifiliis or Ich.In addition to <strong>Georgia</strong>’s food fish industry, there is an increasing interest inornamental fish production. As <strong>Georgia</strong>’s aquaculture industries continue togrow, research aimed at improving the health <strong>of</strong> aquatic animal species willultimately help growers reduce production costs and improve pr<strong>of</strong>its.Role <strong>of</strong> Signaling Phosphoproteins inCatfish Antibacterial Innate ResistanceNonspecific cytotoxic cells (NCC) are theteleost equivalent <strong>of</strong> mammalian natural killercells. NCC lyse protozoa and tumor cells andNCC may participate in anti-bacterial resistanceby the release <strong>of</strong> cytokines and amplification<strong>of</strong> inflammatory responses. We haverecently identified an antigen receptor (i.e.,natural killer receptor protein-1/NCCRP-1) onthe membrane <strong>of</strong> NCC. Cross-linkage <strong>of</strong> thisreceptor with monoclonal antibody ortumor/protozoan antigen initiates a downstreamsignaling process that eventually activatescytotoxicity. A major consequence <strong>of</strong> thisactivation/signaling process is the phosphorylation<strong>of</strong> many different intermediate proteinsnecessary for NCC function. In the presentstudy, we identified different “species” <strong>of</strong>phosphoproteins. NCCRP-1 was phosphorylatedon both tyrosine and serine residues. Thiswas identified in Western blots using monoclonalantibodies specific for phosphotyrosineand phosphoserine residues. BOX-1 motifs areproline-rich consensus sequences found on theN-terminus <strong>of</strong> NCCRP-1 and on differentcytokine receptors, on growth hormone receptors,and so on. These motifs are the knowndocking sites for JAK kinases. NCC membranelysates were treated with the chemical crosslinkerDSS, and it was found that JAK-2 wasphysically associated with NCCRP-1.Additional data suggesting that NCCRP-1 is animportant signaling phosphoprotein was thepresence <strong>of</strong> STAT-6 in NCC cytosol preparations.Evidence that this protein may be associatedwith transcriptional activation was shownby demonstrating that STAT-6 translocates tothe NCC nucleus. These studies demonstratedthat NCCRP-1 may be responsible for bothsignaling responses and gene transcriptionalactivation.Liliana Jaso-Friedmann and Donald L. Evansdevans@calc.vet.uga.eduCatfish Immune Response to PlasmidVaccinationChannel catfish (Ictalurus punctatus)farming accounts for approximately half thetotal aquaculture production and farm gatevalue in the United States. Compared with terrestrialfood animal production industries, verylittle is known about the health managementaspects <strong>of</strong> channel catfish, especially withregard to infectious disease. As with mostcommercially important food animals, there isa pressing need for safe, effective, and inexpensivevaccines in the channel catfish cultureindustry. DNA-mediated vaccines, or plasmidvaccines, are a rapidly emerging variation <strong>of</strong>subunit vaccines. The long-range goal <strong>of</strong> thisresearch is to develop safe, effective, andaffordable plasmid vaccines for infectious diseasesimportant to the channel catfish cultureindustry. The current objective in pursuit <strong>of</strong>this goal is to investigate the catfish immuneresponse, both humoral and cellular, generatedby immunization with a plasmid vaccine. Ourlaboratory has demonstrated that foreign proteingenes under the control <strong>of</strong> mammaliantranscription promoters will be expressed bychannel catfish cells both in vitro and in vivo.Our expectations are that, at the end <strong>of</strong> thisproject, we will have demonstrated that channelcatfish will mount a humoral and cellmediatedimmune response against an in vivoexpressed foreign antigen delivered by plasmidvaccination. These observations will providepreliminary data that will facilitate funding forfuture research towards the development <strong>of</strong>vaccines targeted against specific channel catfishdisease agents, such as channel catfishvirus and the bacterium Edwardsiella ictaluri.Steven E. Poet and Donald E. Evanspoets@calc.vet.uga.edu12


Cattle and Other RuminantsCattle, sheep, and goats are three <strong>of</strong> <strong>Georgia</strong>’s important food-animal ruminants.They are considered ruminants because their four-chambered stomach enablesthem to digest copious roughage, which is inedible for direct humanconsumption. These three industries have gone through recent dynamic changes.The beef and dairy industries have liquidated their herds because <strong>of</strong> a relativelylarge cattle supply, high grain market, and low milk and beef prices. Today’s cattleproducers are working with narrow pr<strong>of</strong>it margins and must watch theirexpenses more closely than ever. Consequently, biomedical researchers arechallenged to provide these industries with ways to maintain healthy animals,which will help reduce production costs. Mastitis, Johne’s disease, brucellosis,pasteurellosis, pneumonia, Infectious Bovine Rhinotracheitis (IBR),Parainfluenza-3 (PI-3), and leptospirosis continue to challenge the immunesystems <strong>of</strong> <strong>Georgia</strong>’s cattle herds. Ruminant herd health as it pertains to foodsafety is also a major concern to consumers and producers. Scientists need toinvestigate pathogenic Escherichia coli, Salmonella, Campylobacter, and otherfood-borne organisms as to their origin, transmission, and prevalence.Surface Immunity against Fescue ToxicosisTall fescue is a major cool weather foragein the humid areas <strong>of</strong> the eastern and southernUnited States. The fescue plants are naturallyinfected with an endophyte fungus(Neotyphodium coenophialum) that is importantfor persistence <strong>of</strong> the grass and for maximumforage production. Endophyte-infectedtall fescue contains ergot alkaloids. Cattlegrazing endophyte-infected tall fescue absorbthese alkaloids and develop fescue toxicosis,which results in decreased weight gains andcalving rates. The negative effect <strong>of</strong> fescuetoxicosis is estimated to exceed $750 millionannually. Various strategies have been developedto reduce or prevent fescue toxicosis.Nevertheless, to date, no management or treatmentprocedure has proved successful. Ourresearch group has been investigating the possibility<strong>of</strong> immunizing cattle against the effects<strong>of</strong> the ergot alkaloids. We have developed avaccine that stimulates antibodies that willbind to the ergot alkaloids. In the presentstudy, we are investigating whether the induction<strong>of</strong> surface immunity (production <strong>of</strong> antibodiesin the mucus covering the digestivetract) will prevent the absorption <strong>of</strong> the ergotalkaloids in ingested fescue forage. Phase one<strong>of</strong> the study will determine if surface antibodiescan be induced by a combination <strong>of</strong> injection<strong>of</strong> the vaccine and nasal infusion <strong>of</strong> thevaccine. The surface immune system is a unit,and stimulation at any internal surface willresult in antibody production at all internal surfaces.Based on the results <strong>of</strong> this phase, anefficacy trial will be done where immunizedand placebo-immunized cattle will be grazedon endophyte-infected tall fescue. The efficacy<strong>of</strong> this vaccine will be determined by measuringthe urinary excretion <strong>of</strong> ergot alkaloids. Wehave determined that cattle excrete ergot alkaloids24 hours after starting to graze endophyte-infectedtall fescue. If these trials aresuccessful, more extensive trials will bedesigned to determine the optimum dose andthe number <strong>of</strong> vaccinations needed to providelong-term protection against fescue toxicosis.Donald L. Dawe, Frederick N. Thompson,Nicholas S. Hill*, and John A. Stuedemann**dldawe@calc.vet.uga.edu*Crop and Soil Sciences**Southern Piedmont Conservation ResearchCenterThe Role <strong>of</strong> Parasite Adhesion Proteins inthe Disease ProcessParasites exploit molecules on the surface<strong>of</strong> host cells by producing adhesion proteinscapable <strong>of</strong> binding to them. The parasite’s goalis to enhance its survival, which as a consequencecontributes to the development <strong>of</strong> diseasein humans and animals. The adhesion proteinsproduced by the parasite are therefore <strong>of</strong>considerable interest, as blocking their interactionwith host molecules should interfere withan important step in the disease process. Thefocus <strong>of</strong> work in this laboratory is to betterunderstand these interactions between parasiteadhesion proteins and the host molecules theybind. The starting point <strong>of</strong> this research is afamily <strong>of</strong> adhesion molecules in the parasitePlasmodium falciparum, an agent <strong>of</strong> humanmalaria. During the past year, the completesequence <strong>of</strong> the gene encoding a new adhesionmolecule has been obtained, and work isunderway to determine how it interacts with13


14Dr. Fred Thompson, a recognized authority in fescue toxicosis, has been workingin this area <strong>of</strong> research for 15 years.target molecules on host cells. Using the DNAsequence <strong>of</strong> this gene, several other putativeadhesion molecules have been identified.There are significant similarities between P.falciparum and several parasite pathogens <strong>of</strong>veterinary importance, most notably speciesBabesia (parasites <strong>of</strong> cattle, horses, and dogs).The techniques and reagents developed for thestudy <strong>of</strong> adhesion molecules in Plasmodiumare now being used to detect similar moleculesin Babesia. The discovery <strong>of</strong> novel adhesionmolecules in Babesia will allow these techniquesto be adapted to the detection <strong>of</strong> adhesionmolecules in a wider array <strong>of</strong> pathogenicparasites that impact human and animal health,such as Cryptosporidium and Eimeria. Theseadhesion molecules are expected to provideimportant new targets for development <strong>of</strong> vaccinesand antiparasite drugs.David S. Peterson and David Allred*dpeterso@calc.vet.uga.edu*<strong>University</strong> <strong>of</strong> FloridaSequential Western Blot Analysis <strong>of</strong> BovineHumoral Immunity to ParatuberculosisJohne’s disease (paratuberculosis) causedby Mycobacterium avium subs. paratuberculosis(MPTB) is a chronic wasting disease <strong>of</strong>ruminants that spreads slowly and may be presentin a herd for years prior to diagnosis. Inthe United States, it is estimated that the prevalence<strong>of</strong> infection is between 5-20%. Infectedcows have diarrhea, decreased milk production,and body condition. Losses to the dairyindustry alone exceed $1.5 billion per year.Though controversial, MPTB may also be ahuman pathogen. Crohn’s disease is a chronictransmural inflammatory disease <strong>of</strong> the intestinaltract that has clinical and pathologic featuressimilar to paratuberculosis. The sequentialhumoral immune response to MPTB is notwell studied, and this lack <strong>of</strong> information hindersdevelopment <strong>of</strong> serologic tests that targetmolecules recognized early in the immuneresponse. The objective <strong>of</strong> this project is toanalyze by Western blot, the sequentialhumoral immune response <strong>of</strong> calves infectedwith MPTB. Our long-term goal is to developserologic diagnostic assays that have greaterpotential to diagnose this chronic disease thanis currently possible. Detection <strong>of</strong> early infectionwould allow producers a better tool toidentify and eliminate MPTB infected cattleand limit spread to other animals and the environment.Holstein calves obtained from herds withMPTB test-negative status were orally inoculatedwith MPTB strain 19698. A Western blotassay to detect MPTB antibody has beendeveloped utilizing enhanced chemiluminescence.Serum samples are collected and analyzedevery four weeks for antibody to MPTBby Western blot. Preliminary data suggest thatby 18 months postinfection, three <strong>of</strong> six MPTBchallenged calves have developed an immuneresponse to an antigen comigrating at the sameapparent molecular mass. One other MPTBchallenged calf has a similar weak immuneresponse that is considered suspicious. Thisimmune response is not seen in sera from anycontrol calves. Antibody from only one <strong>of</strong> theMPTB challenged calves identified this antigenbefore 15 months indicating that the number<strong>of</strong> MPTB calves mounting an immuneresponse to this antigen is significantlyincreasing. Identification <strong>of</strong> MPTB specificantigens may provide candidate molecules thatcan be targeted for improved diagnostic assaysfor this chronic disease.Gordon A. Hullinger, Murray E. Hines II,John R. Cole, Charles A. Baldwingah@tifton.cpes.peachnet.eduA Survey <strong>of</strong> Genes Expressed in BovineSkeletal MuscleBeef, a major food commodity, is comprised<strong>of</strong> the products <strong>of</strong> genes expressed inbovine muscle tissue, yet our knowledge <strong>of</strong>these genes is currently limited. Accordingly,as a first step toward the identification, characterization,genetic mapping, and monitoring <strong>of</strong>expression <strong>of</strong> muscle genes influencing beefquality traits, we have initiated a bovine muscleEST (Expressed Sequence Tag) project.This work involves the isolation and partialsequencing <strong>of</strong> numerous unique cDNAs from abovine skeletal muscle cDNA library. Thesequences can be analyzed in light <strong>of</strong>their homologies to the expanding databases <strong>of</strong>human sequences; inferences can be madeabout their map locations via comparativemapping; and the set <strong>of</strong> sequences provides abasis for further study into the molecular regulation<strong>of</strong> muscle structure and function.Royal A. McGrawmcgraw@bscr.uga.edu


The Use <strong>of</strong> in situ Hybridization to DetectBovine Cytokines in TissueCytokines are a diverse group <strong>of</strong> low molecularweight proteins that modulate virtuallyall biological processes. In infectious diseases,cytokines are particularly important, becausethe outcome <strong>of</strong> an infection depends largely onthe interplay between the infectious agent andthe cytokines induced by the host and modulatedby the agent. Studying the interactionsbetween the infectious agent and the cytokinecan best be done through in situ hybridization,a process allowing for visualization <strong>of</strong> thecytokine within the tissue using nucleic acidprobes. We have made probes to many <strong>of</strong> themain bovine cytokines, including interleukin(IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor(TNF)-α , interferon (IFN)-γ , and IFN-α .Using in situ hybridization, we have examinedthe presence <strong>of</strong> these cytokines in tissues fromcattle infected with Mycobacterium bovis andfoot-and-mouth disease. In tuberculous cattle,TNF-α and IL-10 are prominent cytokines.Interleukin-10 is noted for its ability to dampenthe cellular immune response, perhapsallowing M. bovis to persist. In foot-and-mouthdisease, two anti-viral cytokines, IFN-α andIFN-γ, are produced in the acute infection, butin quantities insufficient to overcome theextremely rapid proliferation <strong>of</strong> the virus.Corrie Browncorbrown@calc.vet.uga.eduIn situ hybridization for vesicular stomatitis viral nucleic acid in neurons <strong>of</strong> cerebral cortex.15


HorsesThe <strong>Georgia</strong> horse industry is experiencing significant growth as more than250,000 horses reside in this state. Equine-related services contribute about $750million to the state’s economy. These numbers are expected to rise as <strong>Georgia</strong>’spopulation continues to grow. The number <strong>of</strong> new equine training programs inthe Southeast continues to expand, and more pr<strong>of</strong>essional trainers have moved tothe Southeast. With this growth comes an increasing concern about equine colicand laminitis. These diseases cause major losses to the equine industry. Thus,VMES researchers have focused on identifying better ways <strong>of</strong> treating horseswith these diseases. To date, researchers have determined the effects <strong>of</strong> bacterialtoxins absorbed during serious episodes <strong>of</strong> colic, developed treatment methodsthat inhibit action <strong>of</strong> some <strong>of</strong> the toxins, developed improved techniques to anesthetizehorses, and identified the earliest changes that occur in the digit <strong>of</strong> horsesthat develop acute laminitis. It is the researchers’ collective goal to learn moreabout the development <strong>of</strong> these diseases so that appropriate measures can bedesigned to prevent them in the future.16Evaluation <strong>of</strong> the Effect <strong>of</strong> Polymyxin BSulfate on ex vivo Endotoxemia in HorsesGram-negative bacterial septicemia andacute gastrointestinal disease are leading causes<strong>of</strong> death in foals and adult horses, respectively.The high mortality rate in these diseasesis associated with the release <strong>of</strong> bacterial endotoxin.Once in the blood, endotoxin binds toand activates leukocytes to secrete mediators,such as tumor necrosis factor, which in turnchannel the host’s defense mechanisms towardself-destruction and shock. The purpose <strong>of</strong> thisproposal is to evaluate polymyxin B sulfate, anantibiotic that binds endotoxin, thereby neutralizingits toxic effects.This project involved an ex vivo model <strong>of</strong>equine endotoxemia in which three doses (100,1000, and10,000 units/kg) <strong>of</strong> polymyxin B sulfateor saline (time and drug control) weregiven as an intravenous bolus to eighthealthy horses. Blood was drawn at varioustimes before and after the administration <strong>of</strong>polymyxin B sulfate (or saline) andEscherichia coli or Salmonella minnesotaendotoxin (1 ng endotoxin/ml blood) wereadded to heparinized blood ex vivo. After a4-hour incubation, the plasma was assayedfor tumor necrosis factor activity. To date,all eight horses have received the threedoses <strong>of</strong> polymyxin B sulfate or saline, andtumor necrosis factor activity results havebeen compiled on six horses for all threedoses <strong>of</strong> polymyxin B sulfate and on threehorses that received the saline control.As expected, incubation <strong>of</strong> blood withendotoxin induced tumor necrosis factoractivity ex vivo. In horses given saline as acontrol, tumor necrosis factor activity wasconsistently induced by endotoxin. Allthree doses <strong>of</strong> polymyxin B sulfate significantlyinhibited endotoxin-induced tumor necrosisfactor. Inhibition was slightly better against E.coli endotoxin, as compared with S. minnesota.Preliminary results indicate that the 10,000units polymyxin B sulfate/kg dose effectivelyinhibited 90% <strong>of</strong> endotoxin-induced tumornecrosis factor activity for up to 6 hours,whereas the 1,000 units/kg dose inhibited 75%<strong>of</strong> endotoxin-induced tumor necrosis factoractivity for 3 hours. The latter dose wouldcost only approximately $10 for a single treatmentfor a 450 kg horse. Signs <strong>of</strong> drug toxicitywere not detected. Our ultimate goal is to identifyan affordable, safe, and effective dose <strong>of</strong>polymyxin B sulfate for the treatment <strong>of</strong>equine endotoxemia in the clinical setting.Michelle H. Barton and Anna Parviainenmbarton@calc.vet.uga.eduDr. Anna Parviainen is preparing serum for anex vivo test for exdotoxin-leukocyte binding inhorses.


Endotoxin Antagonists: Characterizing theirInteraction with Equine MonocytesDiseases characterized by endotoxemiaremain the largest cause <strong>of</strong> death in horsesnationwide. In equine veterinary practice,endotoxemia occurs most frequently in horseswith colic and foals with septicemia. For thesereasons, we have initiated studies designed toidentify the mechanisms by which endotoxincauses its deleterious effects and have initiatedtreatments to prevent these effects. The results<strong>of</strong> our previous studies indicated that peripheralblood monocytes play a key role in thedevelopment <strong>of</strong> many <strong>of</strong> the complicationsassociated with endotoxemia. Consequently,the goals <strong>of</strong> this study were to characterize thebinding <strong>of</strong> fluorescent endotoxin molecules tohorse monocytes using flow cytometry andthen to determine if unique endotoxin moleculesisolated from nitrogen-fixing organismsfrom plants would serve as antagonists <strong>of</strong>endotoxin activity in horses. Initially, we determinedthat excessively high concentrations(10 µgrams/ml) <strong>of</strong> commercially available fluorescentendotoxins had to be used to detecttheir binding to the horse monocytes. Theseconcentrations exceeded those measured in thecirculation <strong>of</strong> horses with colic by more than1,000-fold. We then adapted a new method tolabel endotoxins with fluorescent markers ourselvesand were able to detect significant bindingto horse monocytes at 6-10 ng/ml. Theresults <strong>of</strong> these experiments will allow us tomore accurately characterize the binding <strong>of</strong>endotoxins to horse cells at concentrations thatoccur in natural cases <strong>of</strong> colic.James N. Moore, Donald L. Evans, andRussell W. Carlson*jmoore@calc.vet.uga.edu*Complex Carbohydrate Research CenterEffect <strong>of</strong> a Hyaluronate Membrane onAdhesions and Anastomotic Healing inHorsesIntra-abdominal adhesions are a commoncause <strong>of</strong> postoperative intestinal obstructionand mortality in horses. Adhesions become aclinical problem when they compress or distortthe intestine and lead to intestinal constrictionor incarceration, predisposing the patient tointestinal obstruction and signs <strong>of</strong> abdominalpain. A bioresorbable hyaluronate membrane(HA-membrane) has been developed to reducepostoperative adhesion formation in people.The HA-membrane is placed on the intestineto prevent serosal-serosal or serosal-peritonealapposition during the early postoperative healing.Agents that reduce adhesion formationwithout adversely effecting normal peritonealhealing may reduce the morbidity and mortalityassociated with abdominal surgery in horses.The purpose <strong>of</strong> this study was to evaluate theeffect <strong>of</strong> a bioresorbable HA-membrane onexperimentally induced adhesion formationand anastomotic healing in horses.The effect <strong>of</strong> a HA-membrane on postoperativeadhesion formation was evaluated in 12healthy horses using an established model <strong>of</strong>serosal trauma to induce intra-abdominal adhesions.Ventral midline celiotomies and twohand-sewn, jejunal resections and end-to-endanastomoses were performed. Two separateareas <strong>of</strong> the jejunum were briskly rubbed 100times using sterile, dry gauze, and three simpleinterrupted chromic gut sutures were placed inthe abraded area. In treated horses (n=6), HAmembraneswere applied to the jejunum tocompletely cover the anastomoses and abradedareas <strong>of</strong> jejunum. Nontreated horses (n=6)served as controls. Horses in both groups wereeuthanatized ten days after surgery. Theabdominal cavity was evaluated for adhesionformation and the jejunal anastomoses evaluatedhistologically for quality <strong>of</strong> healing.Fibrous adhesions were associated withboth abraded jejunal sites in all six controlhorses. Of the treated horses, only one abrasionsite <strong>of</strong> one horse formed an adhesion.There were significantly fewer adhesions at thejejunal abrasion sites in the HA-membranegroup as compared with the control group.There were no differences in anastomotic healingbetween groups.The results <strong>of</strong> this study suggest that inhorses at an increased risk <strong>of</strong> intra-abdominaladhesion formation, the use <strong>of</strong> HA-membranesduring exploratory celiotomy may reduce themorbidity and mortality associated withabdominal surgery.P. O Eric Mueller, William P Hay,Barry G. Harmon, and Lisa Amorosoemueller@calc.vet.uga.eduDr. Eric Mueller examines a client’s horse at the Large Animal Teaching Hospital.17


SwineMany <strong>of</strong> <strong>Georgia</strong>’s hog producers have recently converted their finishing unitsinto farrowing houses. More hog operations are sending their two-week-old pigsto nurseries in neighboring states and to finishing floors and packing plants inthe Midwest. Propelling this change was the closing <strong>of</strong> the state’s only majorswine processing plant in June 1996.With these changes in production scheme, biomedical researchers are focusingon the health needs <strong>of</strong> a sow production system. <strong>Georgia</strong> scientists are workingto improve herd health by eliminating porcine reproductive and respiratory syndrome(PRRS), pseudorabies, and brucellosis. With respect to food safety, VMESscientists are testing ways to reduce the numbers <strong>of</strong> microbial agents in<strong>Georgia</strong>’s hog farms, thereby reducing human foodborne pathogens.18Inflammatory Cytokine Expression in SwineLymphoid Tissue Experimentally Infectedwith Mycobacterium avium Serovar 2Swine mycobacteriosis (tuberculosis) is acommon cause <strong>of</strong> carcass condemnation inSouth <strong>Georgia</strong> swine. Once the infection isestablished in a swine herd, it is difficult toeffectively prevent or eliminate the disease.Mycobacterium avium infections in swine are<strong>of</strong> great economic importance to swine producersin <strong>Georgia</strong> and other regions with highswine populations. The maximum incidence <strong>of</strong>detectable lesions <strong>of</strong>ten corresponds to traditionalslaughter weights. As clinical signs areusually not apparent at slaughter, considerablefinancial loss to producers occurs due to carcasscondemnations. Evaluation <strong>of</strong> in vivomRNA cytokine pr<strong>of</strong>iles in lymphoid tissuefrom swine infected with M. avium shouldallow the elucidation <strong>of</strong> cytokine interactionsinvolved in clearance <strong>of</strong> the organism and resolution<strong>of</strong> lesions. We hypothesize that thecytokine secretion pr<strong>of</strong>ile in infected swinelymphoid tissue is altered from the normalstate by local factorspresent on or secretedby M. avium;thereby preventingan appropriateimmune responsecapable <strong>of</strong> effectiveclearance and prevention<strong>of</strong> disease.Our objective is toevaluate the inflammatorycytokinemRNA expression(TNF, IL-1, IL-6,and IL-8) <strong>of</strong> swinelymphoidtissue (mandibularlymph node and tonsil)experimentallyinfected (160 days postinoculation) with M.avium serovar 2 by morphological localization<strong>of</strong> cytokine mRNA by in situ oligoprobehybridization. Preliminary data suggest amarked increase in TNF expression, a mildincrease in IL-8 expression, and a mildincrease in IL-1 expression in mandibularlymph nodes from infected swine. A mildincrease in IL-6 expression was observed intonsils from infected swine. This data on localizedcytokine expression (in vivo) at a stage <strong>of</strong>disease where a cell-mediated response isactive in resolution <strong>of</strong> the disease should allowdevelopment <strong>of</strong> more effective vaccine.Murray E. Hines II, Kendall S. Frazier,Corrie C. Brownmhines@tifton.cpes.peachnet.eduDr. Corrie Brown testing swine for Mycobacterium avium.


Wildlife<strong>Georgia</strong>’s wildlife habitat is continually changing as more people and domesticanimals move into the countryside. This change brings concerns about diseaseinteraction among wildlife, domestic animals, and humans. In addition, hunting,a popular form <strong>of</strong> wildlife recreation, adds hundreds <strong>of</strong> millions <strong>of</strong> dollars to<strong>Georgia</strong>’s economy, and as such, depends on the health <strong>of</strong> the state’s wildlife.VMES researchers are studying many wild species, including white-tailed deer,wild turkeys, wild swine, foxes, raccoons, skunks, small rodents, and songbirds,to learn more about each animal’s role in disease maintenance and transmission.Recent research projects have involved diseases such as rabies, Escherichia coliO157:H7, leptospirosis, ehrlichiosis, Lyme disease, pseudorabies, swinebrucellosis, sarcoptic mange, and mycoplasmosis. Although research objectivesvary by project, the main goals are to determine the importance <strong>of</strong> each diseaseto the health <strong>of</strong> wildlife, domestic animals, and people, and to devise ways tominimize that disease’s undesirable impact. At times, researchers have identifiedwildlife as a key part <strong>of</strong> a specific disease problem, but there also are numerousinstances in which studies clearly demonstrate that wildlife is not involved.Either way, research provides the understanding that is required before rationalsolutions are possible to maintain a healthy environment for <strong>Georgia</strong>’s peopleand animals.P-selectin Regulation in EpizooticHemorrhagic Disease Virus InfectionThe epizootic hemorrhagic disease viruses,along with the closely related bluetongueviruses, cause a devastating disease in whitetaileddeer commonly known as hemorrhagicdisease. These viruses occasionally cause diseasein cattle, and the bluetongue viruses causesignificant morbidity and mortality in sheep.Although it is known that these viruses infectand kill the cells that line blood vessels resultingin severe hemorrhage, infection <strong>of</strong> thesecells no doubt triggers other events that eitherpotentiate or ameliorate the disease. P- and E-selectin are proteins that are expressed on thesurface <strong>of</strong> the cells lining the blood vesselswhen these cells are activated by a variety <strong>of</strong>insults. When expressed, these proteins directthe migration <strong>of</strong> cells involved in cellularimmunity, inflammation, or hemostasis to sites<strong>of</strong> vascular injury. Little is known, however,about the expression or role <strong>of</strong> selectins duringviral infections. We have found that both P andE selectin are expressed on the cells lining theblood vessels during epizootic virus infection,both in vitro and in vivo. Expression was higherin cattle, which rarely develop disease followinginfection, than in the extremely susceptiblewhite-tailed deer. This low-level <strong>of</strong>selectin expression in white-tailed deer followinginfection with epizootic hemorrhagic diseasevirus may partially explain the extremesusceptibility <strong>of</strong> deer to these viruses.Elizabeth W. Howerth and David E. Stallknechtehowerth@calc.vet.uga.edu<strong>Veterinary</strong> student Debbie Perzak, a participantin the Merck Summer Scholar ResearchProgram, working on vesicular stomatis virus.Survey <strong>of</strong> Wild White-tailed Deer in<strong>Georgia</strong> for Escherichia coli O157:H7Cattle are a source <strong>of</strong> the human foodbornepathogen Escherichia coli O157:H7.Deer also are suspected as a source because <strong>of</strong>recent isolations <strong>of</strong> the bacteria from deerfeces and confirmation <strong>of</strong> venison as thesource <strong>of</strong> two small clusters <strong>of</strong> human disease19


in Oregon. The objective <strong>of</strong> this study was todetermine if white-tailed deer in <strong>Georgia</strong> carryE. coli O157:H7.During summer 1997, more than 300 freshdeer fecal samples were collected from theground at five <strong>Georgia</strong> wildlife areas. Duringautumn 1997, nearly 400 fecal samples werecollected directly from hunter-killed deer at thesame locations plus an additional area. Fecalsamples were cultured for E. coli O157:H7.All samples collected from the groundwere culture-negative. Three samples (0.8%)collected directly from deer were positive forE. coli O157:H7. The three isolates were from77 deer sampled (3.8%) during November atone area. Two <strong>of</strong> the three isolates had identicalDNA fingerprints. All three isolates producedShiga-like toxins 1 and 2. Samples <strong>of</strong>frozen processed meat from the three positivedeer were culture-negative for E. coliO157:H7.Results <strong>of</strong> this study suggest that the overallprevalence <strong>of</strong> E. coli O157:H7 is low infree-ranging deer; however, there may be focalareas where deer harbor the bacteria. Cattlewere present in the vicinity where the positivedeer were found, but they also were present atother sites where deer were culture-negative.Additionally, the results suggest that contamination<strong>of</strong> meat did not occur during field dressingand processing <strong>of</strong> the three deer carryingE. coli O157:H7.John R. Fischer, Tong Zhao, andMichael P. Doyle *jfischer@calc.vet.uga.edu* Food Science and TechnologyExperimental Infection <strong>of</strong> Deer Mice withVesicular Stomatitis VirusVesicular stomatitis (VS) is a viral disease<strong>of</strong> cattle, horses, and swine, that causes substantialeconomic losses to livestock producers.The epidemiology <strong>of</strong> this disease is currentlyundefined, but it is suspected that the virus ismaintained in a vertebrate/insect vector cycleinvolving wildlife. To determine if native wildrodents may be involved in this cycle, a pilotstudy involving experimental infection <strong>of</strong> 100deer mice (Peromyscus maniculatus) withvesicular stomatitis virus (VSV), New Jersey(NJ) serotype, was performed. The virus usedin this study was originally isolated from sandflies collected on Ossabaw Island, <strong>Georgia</strong>.Viremia was detected in infected mice duringpostinoculation days one through three. Viruswas isolated from various tissues from 96 <strong>of</strong>100 mice from postinoculation days onethrough seven, and virus isolation results wereconfirmed by polymerase chain reaction(PCR), immunohistochemical detection <strong>of</strong>virus in tissues, and in situ hybridization <strong>of</strong>viral RNA in tissues. Following this pilotstudy, a series <strong>of</strong> experiments were conductedto compare the outcome <strong>of</strong> infection in deermice with two different strains <strong>of</strong> VSV-NJ. TheOssabaw Island strain was compared with aVSV-NJ isolate from a recent VS outbreak(1995) in Colorado, with emphasis on development<strong>of</strong> viremia, clinical outcome, and distribution<strong>of</strong> virus in tissues. The Colorado strain <strong>of</strong>VSV-NJ produced a significantly higher level<strong>of</strong> viremia and caused central nervous systemdisease sooner than the Ossabaw Island strain<strong>of</strong> VSV-NJ. Further experiments using thisdeer mouse model are planned to investigatethe effects <strong>of</strong> route <strong>of</strong> inoculation and dose <strong>of</strong>virus on development and extent <strong>of</strong> viremia,the effects <strong>of</strong> pregnancy on infection, andeventually, the potential for viremic deer miceto infect appropriate insect vectors. Resultsfrom this study provide the first evidence that avertebrate host can become viremic and thusprovide a source <strong>of</strong> VSV-NJ to biting arthropodsand eventually livestock. Results alsoindicate that the deer mouse can provide avaluable research tool to further study vectorcompetence <strong>of</strong> suspected biting insect species.David E. Stallknecht, Elizabeth W. Howerth,and Todd E. Cornishdstall@calc.vet.uga.edu20


Companion AnimalsCompanion animals reside in 55 million U.S. homes. These animals include anestimated 66 million cats, 58 million dogs, 88 million fish, 40 million birds,13 million small animals (rabbits, hamsters, and gerbils), and 8 million reptiles.Companion animals’ popularity can be attributed to aging baby boomers lookingto pets for companionship after their children leave home. And while U.S. petownership is at an all-time high, these animals are living longer than theirpredecessors because <strong>of</strong> medical advances. Longer life, however, means moreage-related diseases and ailments, such as cancer, neural degeneration, kidneydysfunction, poor circulation, decreased respiratory capacity, and decreased liverfunction.It is up to biomedical researchers to come up with treatments for these and otherdiseases and ailments that affect companion animals. Nevertheless, unlike otherresearch areas, no federally funded support exists for studies that specificallybenefit companion animals. Yet, many <strong>of</strong> these studies affect human medicine.For example, articificial hip studies were initially performed on dogs in order todevelop a model for replacing diseased hips in humans. Now older dogsroutinely undergo joint replacement. This is just one <strong>of</strong> many examples <strong>of</strong> howbiomedical research benefits both human and animal health.Canine Hepatocerebellar Degeneration: APotential Model <strong>of</strong> CDGS1Dr. Paige Carmichael explains the pathogenesis<strong>of</strong> CHD to a group <strong>of</strong> visiting pathologists.Canine Hepatocerebellar Degeneration(CHD) is an insidious and debilitating neurologicdisorder that has been described inBernese Mountain Dogs, although it is conceivablethat other breeds may also be affected.We have determined that this syndrome is anautosomal recessive inherited cerebellar corticaldegenerative disease that has consistenthepatic involvement. CHD is biochemicallyand morphologically similar to a recentlymapped human genetic disorder known asCarbohydrate-deficient GlycoproteinSyndrome type 1 (CDGS1). We are studying agroup <strong>of</strong> related purebred Bernese MountainDog puppies with CHD and intend to examineboth the pathogenesis <strong>of</strong> Purkinje cell degenerationin this newly described disease in dogs aswell as probe the underlying molecular geneticbasis <strong>of</strong> the disease. Development <strong>of</strong> a genetictest for carrier animals will provide an effectiveand humane way to breed healthy animalsand to prevent the perpetuation <strong>of</strong> this diseasewithin the breed.K. Paige Carmichael and Royal A. McGrawkpc@calc.vet.uga.edu21


Pharmacokinetics <strong>of</strong> Troglitazone, a NewAnti-diabetic Agent in the CatDiabetes mellitus is an importantendocrine disease in the cat. About 50% <strong>of</strong>diabetic cats have the noninsulin-dependentform characterized by several metabolic alterations,most prominently hyperglycemiacaused by increased hepatic glucose output,increased gluconeogenesis, and hyperlipidemia.Currently, diabetic cats are treatedeither with insulin or the oral drug, glipizide.Both treatments are associated with problems.Cats have variable responses to insulin, andlarge fluctuations in glucose occur frequentlymaking insulin treatment a frustrating experiencefor the owner and dangerous for the cat.Glipizide treatment is not successful at all inmany cats or is successful only for a limitedtime period. Both lead to an increase in insulinconcentrations, which causes weight gain anddeterioration in the insulin resistant state. Thethiazolidinedione, troglitazone, has recentlybeen approved for the treatment <strong>of</strong> diabetes inpeople. This drug improves insulin resistance,hyperglycemia, and hyperinsulinemia in bothdiabetic and nondiabetic obese patients andleads to a normalization <strong>of</strong> the hyperlipidemia.This drug might also be valuable in the treatment<strong>of</strong> the diabetic cat.To use troglitazone in the diabetic cat, weestablished pharmacokinetic parameters fortroglitazone by single dose intravenous andoral administration studies in healthy normoglycemiccats first. This information is necessarybefore troglitazone can be given to diabeticanimals.Margarethe Hoenig, Duncan C. Fergusonmhoenig@calc.vet.uga.eduThe Effect <strong>of</strong> Canine Distemper Virus onMouse Motor Neuron Viability andPhysiologyCanine distemper virus infects both petand wild canids producing severe disease <strong>of</strong>the immune, respiratory, gastrointestinal andnervous systems. Untreated animals that survivethe acute illness usually die from fatalencephalitis. The neuropathology produced byCDV is similar to that produced in MultipleSclerosis. In spite <strong>of</strong> this, little informationexists concerning the exact cellular mechanisms<strong>of</strong> this virus in the nervous system.Current control <strong>of</strong> the virus in the pet dog populationentails vaccination. In spite <strong>of</strong> thesecontrol measures, CDV is still a leading cause<strong>of</strong> infectious encephalitis in dogs. In <strong>Georgia</strong>alone, CDV was second only to parvovirus inthe number <strong>of</strong> infectious disease cases reportedto the <strong>Georgia</strong> <strong>Veterinary</strong> Diagnostic Laboratoriesbetween 1993-1995 (420 cases/3 years).The reasons for continued existence <strong>of</strong> the diseaseinclude unvaccinated animals, vaccinefailure, persistence <strong>of</strong> the virus in wild canids,and the existence <strong>of</strong> an inadequately controlledroaming dog population. A study <strong>of</strong> CDV inthe gray fox population <strong>of</strong> the southeasternstates found that the disease occurred in 78%<strong>of</strong> the dead or sick foxes studied. It is noteworthythat 75% <strong>of</strong> the animals were from<strong>Georgia</strong>. In addition, CDV infection has alsobeen reported in coyotes in <strong>Georgia</strong> and SouthCarolina. Therefore, it is likely that CDV willcontinue to be a significant threat to domesticcanids and wildlife in <strong>Georgia</strong>. This warrantsadditional research in understanding its mechanisms<strong>of</strong> action at the cellular level, as well asthe development <strong>of</strong> more effective treatmentand control measures. The objective <strong>of</strong> the currentstudy is to develop an in vitro model systemthat can be used to study the action <strong>of</strong>CDV at the cellular level. Currently, we areusing mouse spinal cord tissue to grow motorneurons in cell culture, and electrical recordingsto measure the activity <strong>of</strong> these cellsbefore and after infection with CDV, in aneffort to better understand the cellular action<strong>of</strong> CDV.Julie A. C<strong>of</strong>fieldc<strong>of</strong>field@calc.vet.uga.edu22Dr. Gina Michels performs a physical examinationon a diabetic cat.Assisted Reproductive Techniques for theTreatment <strong>of</strong> Canine InfertilityDue to the increasing numbers <strong>of</strong> valuablecanine patients being seen by the <strong>Veterinary</strong>Medical Teaching Hospital for reproductiveproblems, this research has been undertaken toprovide new clinical therapeutic modalities formany <strong>of</strong> these otherwise untreatable diseases.Although assisted reproduction rarely <strong>of</strong>fers acure, it does allow for the procreation <strong>of</strong> valuedbut otherwise sterile patients. The followingis a summary <strong>of</strong> the canine specific


esearch paid for by VMES funds where weinvestigated the harvesting <strong>of</strong> oocytes, in vitromaturation <strong>of</strong> oocytes, in vitro capacitation <strong>of</strong>canine spermatozoa, and two in vitro fertilizationtechniques.Harvesting <strong>of</strong> oocytes by the dissectionmethod was significantly (p


Financial HighlightsResearch FundingFunding Source * Fiscal Year ‘97 Fiscal Year ‘98VMES Budget $2,887,931 $2,984,133Federal Grants and Contracts 1,282,230 1,327,683State Grants and Contracts 109,770 142,650Private Grants and Contracts 2,104,767 2,904,553*Excluding carryover funds<strong>Georgia</strong> Livestock and Poultry: Inventories and Values aNumber on FarmsSpecies and/or Produced Production ValueCattle Beef 1,392,000 $497,220,000Dairy 98,000 355,680,000 bHogs 1,640,000 209,200,000Poultry Broilers 1,182,800,000 2,276,890,000Non-broilers 19,869,000 17,112,000Eggs 4,867,000,000 358,941,000Turkeys 175,000 2,591,000Horses and Ponies 251,000 125,500,000aBased in part on information published by the <strong>Georgia</strong> Agricultural Statistics Service, Athens, <strong>Georgia</strong>bIncludes value to dairy cattle and milk produced<strong>Georgia</strong> Farm Cash ReceiptsCrops and Farm Forest (43.8%)Poultry and Eggs (44.3%)Dairy Products (4.2%)Meat Products (6.9%)Other Livestock (0.8%)24


Research Contracts and GrantsAllen, S.W. Pharmacokinetics and efficacy <strong>of</strong> transdermalfentanyl patches in cats and their effect on serum cortisolconcentrations. American <strong>College</strong> <strong>of</strong> <strong>Veterinary</strong>Surgeons, $10,000.The use <strong>of</strong> Monocryl in feline ovariohysterectomy.Mallinckrodt <strong>Veterinary</strong>, Inc., $4,000.Barton, M.H. Evaluation <strong>of</strong> the effects <strong>of</strong> polymyxin b onex vivo endotoxemia in horses. American <strong>Veterinary</strong><strong>Medicine</strong> Foundation, $12,998.The effects <strong>of</strong> endotoxin on equine leukocyte receptorexpression. U.S. Department <strong>of</strong> Agriculture, $16,561.Bounous, D.I. Genetic resistance through cellular immunemechanisms during the early phase <strong>of</strong> Marek’s diseaseinfection. U.S. Poultry and Egg Association, $32,261.Brown, S.A. Choice <strong>of</strong> antihypertensive agents in cats.Morris Animal Foundation, $31,386.Obesity, systemic hypertension, and progressive renaldisease in dogs. Morris Animal Foundation, $25,673.Potential benefits <strong>of</strong> benazepril in cats with chronicrenal insufficiency. Novartis Animal Health, $12,022.Brown, T.P. Study <strong>of</strong> spiking mortality <strong>of</strong> turkeys. NorthCarolina State <strong>University</strong>, $64,310.Diagnostics for avian enteric coronavirus infections incommercial poultry. U.S. Department <strong>of</strong> Agriculture,$10,205.Budsberg, S.C. Comparison <strong>of</strong> perioperative analgesiceffects <strong>of</strong> meloxicam and butorphanol in dogs undergoingstabilization <strong>of</strong> the stifle for cranial cruciate rupture.Boehringer Ingelheim Animal Health, Inc.,$42,150.Role <strong>of</strong> n-3/n-6 fatty acids in the development <strong>of</strong>degenerative joint disease: A dog stifle model. Hill’sPet Nutrition, Inc., $16,500.The effects <strong>of</strong> carpr<strong>of</strong>en on the ground reaction forcesin a canine chronic stifle osteoarthritis model. Pfizer,Inc., $28,279.Crowell-Davis, S.L. Effect <strong>of</strong> litterbox location on normaland inappropriate elimination behavior in cats. The PetCare Trust, $8,758.Dickerson, H.W., Jr. Can a DNA vaccine induce cutaneousimmunity in fish? Cornell <strong>University</strong>, $20,065.Dreesen, D.W. Antibody response to Rab Avert in veterinarystudents. Chiron Behring GmbH & Co., $55,994.The evaluation <strong>of</strong> safety and immunogenicity <strong>of</strong> a newchromatographically purified rabies vaccine (CPRV) inhealthy adult volunteers. Connaught Laboratories, Inc.,$19,424.Edwards, G.L. Afferent mediation <strong>of</strong> Amylin action.Amylin Pharmaceuticals, $3,000.Effect <strong>of</strong> CLA Supplementation in Dogs. Hill’s PetNutrition, Inc., $70,000.Evans, D.L. Analysis <strong>of</strong> chicken lymphocytes respondingto Campylobacter extracts. U.S. Department <strong>of</strong>Agriculture, $10,000.Streptococcus intial infections in trout and tilapia. U.S.Department <strong>of</strong> Agriculture, $133,200.Fayrer-Hosken, R. Development <strong>of</strong> a natural injectablesterilant vaccine for dogs and cats and the elucidation<strong>of</strong> a synthetic sterilant vaccine for dogs and cats. SpaySafe LLC, $729,687.Immunocontraception in African elephant usingporcine zona pellucida vaccine. Humane Society <strong>of</strong> theUnited States, $28,990.Investigating potential for PZP immunosterilization <strong>of</strong>feral pigs. The Nature Conservancy, $7,500.Ferguson, D.C. Production <strong>of</strong> a highly sensitive caninethyrotropin immunoassay using bioluminescence.<strong>Georgia</strong> Institute <strong>of</strong> Technology, $46,000.Finco, D.R. Beneficial effects <strong>of</strong> an ultralow phosphorusdiet on dogs with induced chronic renal failure. TheIAMS Company, $28,966.Garcia, M. Development <strong>of</strong> polymerase chain reactiondiagnostic method capable <strong>of</strong> distinguishing amonginfectious laryngotracheitis strains. U.S. Department <strong>of</strong>Agriculture, $3,650.Hanson, W.L. Evaluation <strong>of</strong> potential antileishmanialdrugs in animal models. U.S. Army, $207,000.Harmon, B.G. Carrier state for toxin-producing bacteriain cattle. U.S. Department <strong>of</strong> Agriculture, $16,010.Hoenig, M.E. Development <strong>of</strong> a specific and sensitiveassay for feline insulin and proinsulin. Morris AnimalFoundation, $11,600.25


Jackwood, M.W. Genetic drift in the Arkansas serotype <strong>of</strong>infectious bronchitis virus. U.S. Poultry and EggAssociation, $61,298.Recombinant vaccines for infectious bronchitis virus.U.S. Department <strong>of</strong> Agriculture, $5,320.Kleven, S.H. Avian mycoplasmosis. U.S. Department <strong>of</strong>Agriculture, $3,620.Maurer, J.J. Identification <strong>of</strong> virulence specific genes inavian Escherichia coli by RAPD PCR. U.S. Poultryand Egg Association, $22,247.The distribution <strong>of</strong> virulence specific genes amongavian Escherichia coli isolates. U.S. Department <strong>of</strong>Agriculture, $1,990.McCall, J.W. Antifilarial drug testing in dogs. WorldHealth Organization, $160,540.Experimental chemotherapy <strong>of</strong> filariasis and screening<strong>of</strong> filaricides. World Health Organization, $104,696.Filariasis repository research services. NationalInstitutes <strong>of</strong> Health, $227,160.Standardization <strong>of</strong> a model for canine ehrlichiosisusing tick (Rhipicephalus sanguineus) induced infections<strong>of</strong> Ehrlichia canis in beagles. <strong>Georgia</strong> State<strong>University</strong>/<strong>Georgia</strong> Research Alliance, $30,000.Standardization <strong>of</strong> a model for canine ehrlichiosisusing tick (Rhipicephalus sanguineus) induced infections<strong>of</strong> Ehrlichia canis in Beagles. Merial Limited,$30,000.McGraw, R.A. Genetics <strong>of</strong> between-breed resistance tonematode infection in sheep. Louisiana State<strong>University</strong>, $136,146.Murray, T.F. Affinity labels for opioid receptors.<strong>University</strong> <strong>of</strong> Maryland, Baltimore, $53,759.Dextrorotatory opioids as probes for PCP receptors.National Institutes <strong>of</strong> Health, $488,249.New reactor for drug discovery libraries. BendResearch, Inc., $32,400.Screening <strong>of</strong> compound derivative libraries for adenosinereceptor affinity. Bend Research, Inc., $3,807.Nettles, V.F. Assess possible risk factors for exposure toEhrlichia. Centers for Disease Control and Prevention,$40,949.Development and evaluation <strong>of</strong> alternate baits fordelivery <strong>of</strong> V-RG rabies vaccine to wildlife. MerialLimited, $66,650.Development and evaluation <strong>of</strong> alternate baits fordelivery <strong>of</strong> V-RG rabies vaccine to wildlife. <strong>Georgia</strong>State <strong>University</strong>/<strong>Georgia</strong> Research Alliance, $66,650.Development <strong>of</strong> scientific information on animal trapsfor selected wild vertebrate species. U.S. Department<strong>of</strong> Agriculture, $53,334.Southeastern cooperative wildlife disease study.Southeastern Association <strong>of</strong> Fish and WildlifeAgencies, $194,920.Rawlings, C.A. Stress incontinence due to intrinsicsphincter deficiency (ISD). Ethicon, Inc., $132,680.In vivo evaluation <strong>of</strong> resorbable urethral stent in thecanine cystoscopy model. Indigo Medical, Inc.,$80,000.Ritchie, B.W. Post-graduate support in zoo/exotic animalpathology. Zoo Atlanta and Riverbanks Zoo, $36,000.Rowland, G.N. Evaluation <strong>of</strong> mechanisms <strong>of</strong> tendon failurein heavy meat-type birds. U.S. Department <strong>of</strong>Agriculture, $2,190.Sander, J.E. Enumeration <strong>of</strong> bacteria before and after disinfection<strong>of</strong> various types <strong>of</strong> SLAT material used tohouse broiler breeders. Riverdale Mills Corporation,$4,029.Investigation <strong>of</strong> hatchery disinfectant efficacy andeffect on broiler production. U.S. Department <strong>of</strong>Agriculture, $2,660.Stallknecht, D.E. Mycoplasma gallisepticum in housefinches and other wild birds. U.S. Poultry and EggAssociation, $34,249.Thayer, S.G. Investigation <strong>of</strong> natural disease outbreaksand field trial studies. U.S. Department <strong>of</strong> Agriculture,$18,980.Thompson, F.N. Evaluation <strong>of</strong> vaccines against fescuetoxicosis. U.S. Department <strong>of</strong> Agriculture, $22,634.Villegas, P. Inoculation study <strong>of</strong> Marek’s disease virus.Pfizer, Inc., $13,014.Isolation, identification, and control <strong>of</strong> avian viruses.U.S. Department <strong>of</strong> Agriculture, $6,585.26


Administrators and AdvisorsThe <strong>University</strong> System <strong>of</strong> <strong>Georgia</strong>Board <strong>of</strong> RegentsEdgar L. Jenkins, Vice ChairmanStephen R. Portch, ChancellorTom Thompson, President<strong>Georgia</strong> Milk Producers, Inc.J. Tom Coleman, Jr., SavannahState-at-Large (2002)A. W. Dahlberg, AtlantaState-at-Large, (2004)Hilton H. Howell, Jr., AtlantaState-at-Large (1999)Charles H. Jones, MaconState-at-Large (2002)Donald M. Leebern, Jr., AtlantaState-at-Large (2005)David H. Averitt, StatesboroFirst District (1999)John Hunt, TiftonSecond District (2004)Shannon L. Amos, ColumbusThird District (2000)Juanita P. Baranco, MorrowFourth District (2005)Elridge W. McMillan, AtlantaFifth District (2003)Kenneth W. Cannestra, AtlantaSixth District (2001)Edgar L. Rhodes, BremenSeventh District (1999)S. William Clark, Jr., WaycrossEighth District (1999)Edgar L. Jenkins, JasperNinth District (2001)Thomas F. Allgood, Sr., AugustaTenth District (2000)Glenn S. White, LawrencevilleEleventh District (2005)Officers and StaffS. William Clark, Jr., ChairmanJames L. Muyskens, Senior ViceChancellor - Academic Affairs/DeputyLindsay Desrochers, Senior ViceChancellor - Capital Resources/TreasurerArthur N. Dunning, Senior ViceChancellor - Human and ExternalResourcesThomas E. Daniel, Vice Chancellor -External AffairsWilliam K. Chatham, Vice Chancellor -FacilitiesBarry A. Fullerton, Vice Chancellor -Student ServicesE. Michael Staman, Vice Chancellor -Information/Instructional Technology/CIOThe <strong>University</strong> <strong>of</strong> <strong>Georgia</strong><strong>University</strong> & <strong>College</strong> AdministratorsMichael F. Adams, PresidentThe <strong>University</strong> <strong>of</strong> <strong>Georgia</strong>Joe L. Key, Vice President for Researchand Associate ProvostThe <strong>University</strong> <strong>of</strong> <strong>Georgia</strong>Keith W. Prasse, Dean<strong>College</strong> <strong>of</strong> <strong>Veterinary</strong> <strong>Medicine</strong>Harry W. Dickerson, Director<strong>Veterinary</strong> Medical Experiment Station<strong>Veterinary</strong> Advisory BoardBetts Berry, President<strong>Georgia</strong> Cattlemen’s AssociationLee Brooks, State Veterinarian<strong>Georgia</strong> Department <strong>of</strong> AgricultureBill Taff, ChairmanEquine Advisory BoardJohn Walters, President<strong>Georgia</strong> Pork Producers AssociationAlan Habagger, President<strong>Georgia</strong> Poultry FederationEd Taylor, President<strong>Georgia</strong> <strong>Veterinary</strong> Medical AssociationJerry Case, Past President<strong>Georgia</strong> <strong>Veterinary</strong> Medical AssociationCouncil to the Advisory BoardGlenn Smith, Executive Vice President<strong>Georgia</strong> Cattlemen’s AssociationMelinda Woliver, DirectorEquine Division<strong>Georgia</strong> Equine Advisory BoardWayne Dollar, President<strong>Georgia</strong> Farm BureauBill Moore, Executive Director<strong>Georgia</strong> Milk Producers, Inc.Roger Bernard, Executive Secretary<strong>Georgia</strong> Pork Producers AssociationAbit Massey, Executive Secretary<strong>Georgia</strong> Poultry FederationJames Scroggs, Executive Director<strong>Georgia</strong> Poultry Lab ImprovementAssociation, Inc.Kelly Scott, President<strong>Georgia</strong> Ratite CouncilM. Randy Clayton, Director<strong>Georgia</strong> Sheep and WoolJames Strickland, Extension VeterinarianThe <strong>University</strong> <strong>of</strong> <strong>Georgia</strong>27


ResearchersAllen, Douglas, Jr., DVM, MS, Associate Pr<strong>of</strong>essor andHospital Director, Large Animal <strong>Medicine</strong>, (706) 542-5558Allen, Sheila W., DVM, MS, Pr<strong>of</strong>essor, Small Animal <strong>Medicine</strong>,and Associate Dean for Academic Affairs, (706) 542-5728Aron, Dennis N., DVM, Pr<strong>of</strong>essor, Small Animal <strong>Medicine</strong>,(706) 542-6387Baldwin, Charles A., DVM, PhD, Associate Pr<strong>of</strong>essor, TiftonDiagnostic Laboratory, (912) 386-3340Barsanti, Jeanne A., DVM, MS, Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6379Barton, Michelle H., DVM, PhD, Associate Pr<strong>of</strong>essor, LargeAnimal <strong>Medicine</strong>, (706) 542-8319Berman, Frederick W., DVM, PhD, Assistant ResearchScientist, Physiology and Pharmacology, (706) 542-0167Bienzle, Dorothee, DVM, PhD, Assistant Pr<strong>of</strong>essor, Pathology,(706) 542-5847Bounous, Denise I., DVM, PhD, Associate Pr<strong>of</strong>essor, Pathology,(706) 542-5846Brackett, Benjamin G., DVM, PhD, Pr<strong>of</strong>essor, Physiology andPharmacology, (706) 542-5859Broderson, J. Roger, DVM, MS, PhD, Pr<strong>of</strong>essor, Pathology,and Director <strong>of</strong> Animal Care, (706) 542-5938Brown, Cathy A., VMD, PhD, Assistant Pr<strong>of</strong>essor, AthensDiagnostic Laboratory, (706) 542-5917Brown, Corrie C., DVM, PhD, Pr<strong>of</strong>essor and Head, Pathology,(706) 542-5842Brown, Scott A., VMD, PhD, Associate Pr<strong>of</strong>essor, Physiologyand Pharmacology, (706) 542-5857Brown, Thomas P., DVM, PhD, Associate Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-2066Budsberg, Steven C., DVM, MS, Associate Pr<strong>of</strong>essor, SmallAnimal <strong>Medicine</strong>, (706) 542-6574Calvert, Clay A., DVM, Pr<strong>of</strong>essor, Small Animal <strong>Medicine</strong>,(706) 542-6378Carmichael, Karen P., DVM, PhD, Assistant Pr<strong>of</strong>essor,Pathology, (706) 542-5834Caudle, Alfred B., DVM, Pr<strong>of</strong>essor, Large Animal <strong>Medicine</strong>,(706) 542-6322Chambers, Jonathan N., DVM, Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6313C<strong>of</strong>field, Julie A., DVM, PhD, Assistant Pr<strong>of</strong>essor, Physiologyand Pharmacology, (706) 542-5979Cole, John R., Jr., PhD, Pr<strong>of</strong>essor, Tifton DiagnosticLaboratory, (912) 386-3340Colvin, Billy M., PhD, Pr<strong>of</strong>essor, Tifton Diagnostic Laboratory,(912) 386-3340Cornelius, Larry M., DVM, PhD, Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6314Crowell-Davis, Sharon L., DVM, PhD, Pr<strong>of</strong>essor, Anatomy andRadiology, (706) 542-8343Davidson, William R., MS, PhD, Pr<strong>of</strong>essor, Wildlife DiseaseStudy, (706) 542-1741Dawe, Donald L., DVM, PhD, Pr<strong>of</strong>essor, Medical Microbiologyand Parasitology, (706) 542-5793Dickerson, Harry W., Jr., BVSC, PhD, Pr<strong>of</strong>essor, MedicalMicrobiology and Parasitology, and Director, <strong>Veterinary</strong><strong>Medicine</strong> Experiment Station, (706) 542-5734Dookwah, Hugh D., DVM, PhD, Assistant Pr<strong>of</strong>essor, Anatomyand Radiology, (706) 542-5595Downs, Myron O., DVM, PhD, Assistant Pr<strong>of</strong>essor, SmallAnimal <strong>Medicine</strong>, (706) 542-6317Dreesen, David W., DVM, MPVM, Pr<strong>of</strong>essor, MedicalMicrobiology and Parasitology, (706) 542-5789Dzimianski, Michael T., DVM, Research Associate, MedicalMicrobiology and Parasitology, (706) 542-8449Edwards, Gaylen L., DVM, MS, PhD, Associate Pr<strong>of</strong>essor,Physiology and Pharmacology, (706) 542-5854Egger, Christine M., DVM, Assistant Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6432Evans, Donald L., MS, PhD, Pr<strong>of</strong>essor, Medical Microbiologyand Parasitology, (706) 542-5796Fayrer-Hosken, Richard, BVSC, DVM, PhD, MRCVS,Associate Pr<strong>of</strong>essor, Large Animal <strong>Medicine</strong>,(706) 542-6451Ferguson, Duncan C., VMD, PhD, Pr<strong>of</strong>essor, Physiology andPharmacology, (706) 542-5864Finco, Delmar R., DVM, PhD, Pr<strong>of</strong>essor, Physiology andPharmacology, (706) 542-5870Fischer, John R., DVM, PhD, Assistant Research Scientist,Wildlife Disease Study, (706) 542-5700Frazier, Kendall S., PhD, Assistant Pr<strong>of</strong>essor, Tifton DiagnosticLaboratory, (912) 386-3340Garcia, Maricarmen, PhD, Assistant Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-5656Glisson, John R., DVM, MAM, PhD, Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-5652Greenacre, Cheryl B., DVM, Assistant Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-2376Greene, Craig E., DVM, MS, Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6380Hall, D. Gregory, DVM, PhD, Assistant Pr<strong>of</strong>essor, Pathology,(706) 542-5832Halper, Jaroslava, MD, PhD, Associate Pr<strong>of</strong>essor, Pathology,(706) 542-5830Harmon, Barry G., DVM, PhD, Pr<strong>of</strong>essor, Pathology,(706) 542-5831Hawkins, Larry L., DVM, Associate Pr<strong>of</strong>essor, Large Animal<strong>Medicine</strong>, (706) 542-6320Hay, William P., DVM, Assistant Pr<strong>of</strong>essor, Large Animal<strong>Medicine</strong>, (706) 542-6368Hines, Murray E., II, DVM, PhD, Assistant Pr<strong>of</strong>essor, TiftonDiagnostic Laboratory, (912) 386-3340Hnilica, Keith A., DVM, MS, Assistant Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6350Hoenig, Margarethe E., Dr. med. vet., PhD, Pr<strong>of</strong>essor,Physiology and Pharmacology, (706) 542-5869Hollett, R. Bruce, DVM, MS, Associate Pr<strong>of</strong>essor, LargeAnimal <strong>Medicine</strong>, (706) 542-5508Howerth, Elizabeth W., DVM, PhD, Associate Pr<strong>of</strong>essor,Pathology, (706) 542-583328


Hullinger, Gordon A., DVM, PhD, Assistant Pr<strong>of</strong>essor, TiftonDiagnostic Laboratory, (912) 386-3340Jackwood, Mark W., MS, PhD, Associate Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-5475Jacobs, Gilbert J., DVM, Associate Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6375Jacobsen, Karen L., DVM, MS, Associate Pr<strong>of</strong>essor, LargeAnimal <strong>Medicine</strong>, (706) 542-9321Jain, Anant V., PhD, Senior Public Service Associate, AthensDiagnostic Laboratory, (706) 542-5919Jaso-Friedmann, Liliana, MS, PhD, Associate ResearchScientist, Medical Microbiology and Parasitology,(706) 542-5808Kaswan, Renee L., DVM, Sr. Research Vet. Ophthalmologist,Small Animal <strong>Medicine</strong>, (770) 687-9997Kemp, Douglas T., D. Pharm., Clinical Pharmacy Associate,Teaching Hospital, (706) 542-5510Kleven, Stanley H., DVM, PhD, Research Pr<strong>of</strong>essor and Head,Avian <strong>Medicine</strong>, (706) 542-5644Latimer, Kenneth S., DVM, PhD, Pr<strong>of</strong>essor, Pathology,(706) 542-5844Lee, Margie D., DVM, PhD, Associate Pr<strong>of</strong>essor, MedicalMicrobiology and Parasitology, (706) 542-5778Li, Wan-I Oliver, DVM, MS, PhD, Associate Pr<strong>of</strong>essor,Physiology and Pharmacology, (706) 542-5853Liggett, Alan D., DVM, PhD, Associate Pr<strong>of</strong>essor, TiftonDiagnostic Laboratory, (912) 386-3340Little, Susan E., DVM, PhD, Assistant Pr<strong>of</strong>essor, MedicalMicrobiology and Parasitology (706) 542-8447Lowder, Michael Q., DVM, MS, Assistant Pr<strong>of</strong>essor, LargeAnimal <strong>Medicine</strong>, (706) 542-6431Lukert, Phil D., DVM, PhD, Pr<strong>of</strong>essor, Medical Microbiologyand Parasitology, (706) 542-5795Mahaffey, Edward A., DVM, PhD, Pr<strong>of</strong>essor and AssociateDean for Public Service and Outreach (706) 542-5716Mahaffey, Mary B., DVM, MS, Pr<strong>of</strong>essor, Anatomy andRadiology, (706) 542-8321Martin, Charles L., DVM, MS, Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-5602Maurer, John J., PhD, Assistant Pr<strong>of</strong>essor, Avian <strong>Medicine</strong>,(706) 542-5071McCall, John W., PhD, Pr<strong>of</strong>essor, Medical Microbiology andParasitology, (706) 542-8449McDonnell, John J., MS, DVM, Assistant Pr<strong>of</strong>essor, SmallAnimal <strong>Medicine</strong>, (706) 542-7415McGraw, Royal A., MS, PhD, Associate Pr<strong>of</strong>essor, Physiologyand Pharmacology, (706) 542-0661Medleau, Linda, DVM, MS, Pr<strong>of</strong>essor, Small Animal <strong>Medicine</strong>,(706) 542-2377Miller-Liebl, Doris M., DVM, PhD, Pr<strong>of</strong>essor and Director,Athens Diagnostic Laboratory, (706) 542-5915Moore, James N., DVM, PhD, Pr<strong>of</strong>essor and Head, LargeAnimal <strong>Medicine</strong>, (706) 542-3325Mueller, P. O. Eric, DVM, PhD, Assistant Pr<strong>of</strong>essor, LargeAnimal <strong>Medicine</strong>, (706) 542-7367Munnell, John F., VMD, PhD, Associate Pr<strong>of</strong>essor, Anatomyand Radiology, (706) 542-8342Murray, Thomas F., PhD, Pr<strong>of</strong>essor and Head, Physiology andPharmacology, (706) 542-3014Nettles, Victor F., DVM, MS, PhD, Pr<strong>of</strong>essor and Director,Wildlife Disease Study (706) 542-1741Neuwirth, Lisa, DVM, MS, Associate Pr<strong>of</strong>essor, Large Animal<strong>Medicine</strong>, (706) 542-6381Newman, Louis E., III, DVM, PhD, Pr<strong>of</strong>essor and Director,Tifton Diagnostic Laboratory, (912), 386-3340Odend’hal, Stewart, DVM, PhD, Associate Pr<strong>of</strong>essor, Anatomyand Radiology, (706) 542-5551Parks, Andrew H., MA, Vet MB, MS, MRCVS, AssociatePr<strong>of</strong>essor, Large Animal <strong>Medicine</strong>, (706) 542-6372Peterson, David S., PhD, Assistant Pr<strong>of</strong>essor, MedicalMicrobiology and Parasitology, (706) 542-5242Poet, Steven E., DVM, PhD, Assistant Pr<strong>of</strong>essor, MedicalMicrobiology and Parasitology, (706) 542-4784Prasse, Keith W., DVM, PhD, Pr<strong>of</strong>essor, Pathology, and Dean,(706) 542-3461Purinton, Paul T., DVM, PhD, Pr<strong>of</strong>essor, Anatomy andRadiology, (706) 542-8302Quandt, Jane E., DVM, MS, Assistant Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6386Ragland, William L., III, DVM, PhD, Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-5647Rakich, Pauline M., DVM, PhD, Associate Pr<strong>of</strong>essor, AthensDiagnostic Laboratory, (706) 542-5568Rawlings, Clarence A., DVM, PhD, Pr<strong>of</strong>essor and Head, SmallAnimal <strong>Medicine</strong>, (706) 542-6385Reeves, David, DVM, Associate Pr<strong>of</strong>essor, Large Animal<strong>Medicine</strong>, (706) 542-9330Ritchie, Branson W., DVM, MS, PhD, Associate Pr<strong>of</strong>essor,Small Animal <strong>Medicine</strong>, (706) 542-6316Roberts, Arthur W., MS, Public Service Associate, AthensDiagnostic Laboratory, (706) 542-5568Roberts, Royce E., DVM, MS, Pr<strong>of</strong>essor and Head, Anatomyand Radiology, (706) 542-8309Rowland, George N., III, DVM, PhD, Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-5084Sander, Jean, DVM, MAM, Associate Pr<strong>of</strong>essor, Avian<strong>Medicine</strong>, (706) 542-5058Sangster, Lowell T., DVM, MS, Assistant Pr<strong>of</strong>essor, TiftonDiagnostic Laboratory, (912) 386-3340Selcer, Barbara A., DVM, Pr<strong>of</strong>essor, Anatomy and Radiology,(706) 542-8305Sharma, Raghubir P., DVM, PhD, Pr<strong>of</strong>essor, Physiology andPharmacology, (706) 542-2788Smith, Frederick G., DVM, PhD, Associate Pr<strong>of</strong>essor, Anatomyand Radiology, (706) 542-5550Stallknecht, David E., MS, PhD, Assistant Research Scientist,Wildlife Disease Study, (706) 542-7952Steffens, Walstine L., PhD, Associate Research Scientist,Pathology, (706) 542-5536Stiles, Jean, DVM, MS, Assistant Pr<strong>of</strong>essor, Small Animal<strong>Medicine</strong>, (706) 542-6369Styer, Eloise L., PhD, Public Service Associate, TiftonDiagnostic Laboratory, (912) 386-334029


Supakorndej, Prasit, MS, PhD, Assistant Research Scientist,Medical Microbiology and Parasitology, (706) 542-8449Thayer, Stephan G., MS, PhD, Senior Public Service Associate,Avian <strong>Medicine</strong>, (706) 542-5057Thompson, Frederick N., Jr., DVM, PhD, Pr<strong>of</strong>essor,Physiology and Pharmacology, (706) 542-5862Trim, Cynthia M., BVSC, MRCVS, Pr<strong>of</strong>essor, Large Animal<strong>Medicine</strong>, (706) 542-6318Villegas, Pedro, DVM, PhD, Pr<strong>of</strong>essor, Avian <strong>Medicine</strong>,(706) 542-5085Weiss, Raul, DVM, Associate Pr<strong>of</strong>essor, Athens DiagnosticLaboratory, (706) 542-5914White, Susan L., DVM, MS, Associate Pr<strong>of</strong>essor, Large Animal<strong>Medicine</strong>, (706) 542-6319Williamson, Lisa, DVM, MS, Associate Pr<strong>of</strong>essor, LargeAnimal <strong>Medicine</strong>, (706) 542-9323Wooley, Richard E., DVM, PhD, Pr<strong>of</strong>essor and Head, MedicalMicrobiology and Parasitology, (706) 542-582530


Selected PublicationsAllen, S.W., Chambers, J.N.: Computer assisted instruction <strong>of</strong>fundamental surgical motor skills. J. Vet. Med. Educ. 24:2-5, 1997.Anderson, D.E., Allen, D., St. Jean, G., Parks, A.H.: Use <strong>of</strong> amultifenestrated indwelling lavage system for treatment <strong>of</strong>septic digital tenosynovitis in cattle. Aust. Vet. J. 75:796-799, 1997.Anderson, M., Palmer, R., Aron, D.N.: Improving pin selectionand insertion technique for external skeletal fixation.Compend. Contin. Educ. Pract. Vet. 19:485-494, 1997.Aron, D.N., Selcer, B.A., Smith, J.D.: Autogenous tensor fascialata graft replacement <strong>of</strong> the patellar ligament in a dog. Vet.Comp. Orthop. Traumatol. 10:141-145, 1997.Arttamangkul, S., Ishmael, J.E., Murray, T.F., Grandy, D.K.,DeLander, G.E., Kieffer, B.L., Aldrich, J.V.: Synthesisand opioid activity <strong>of</strong> conformationally constrained dynorphinA analogues: Part II. Conformational constraint in the“address sequence.” J. Med. Chem. 40:1211-1218, 1997.Barsanti, J.A.: Management <strong>of</strong> urinary tract infections in dogs.Ir. Vet. J. 30:385-392, 1997.Barton, M.H., Ferguson, D.C., Davis, P.J., Moore, J.N.:The effects <strong>of</strong> pentoxifylline infusion on plasma 6-ketoprostaglandinF1 alpha and ex vivo endotoxin-induced tumornecrosis factor activity in horses. J. Vet. Pharmacol. Ther.20:487-492, 1997.Barton, M.H., Moore, J.N., Norton, N.: Effects <strong>of</strong> pentoxifyllineinfusion on response <strong>of</strong> horses to in vivo challengeexposure with endotoxin. Am. J. Vet. Res. 58:1300-1307,1997.Barton, M.H., Morris, D.D., Norton, N., Prasse, K.W.:Hemostatic and fibrinolytic indices in neonatal foals withpresumed septicemia. J. Vet. Intern. Med. 12:26-35, 1998.Baskett, A., Barton, M.H., Norton, N., Anders, B., Moore,J.N.: Effect <strong>of</strong> pentoxifylline, flunixin meglumine, and theircombination on a model <strong>of</strong> endotoxemia in horses. Am. J.Vet. Res. 58:1291-1299, 1997.Berman, F., Murray, T.F.: Domoic acid neurotoxicity in culturedcerebellar granule neurons is predominantly mediatedby NMDA receptors that are activated as a consequence <strong>of</strong>excitatory amino acid release. J. Neurochem. 69:693-703,1997.Brandon, C.I., Srivastava, P.M., Heusner, G.L., Fayrer-Hosken, R.A.: Extraction and quantification <strong>of</strong> acrosin,beta-N-acetylglucosaminidase, and arylsulfatase-A fromequine ejaculated spermatozoa. J. Exp. Zool. 279:301-308,1997.Brown, C.C.: A review <strong>of</strong> three pathology-based techniques forretrospective diagnosis <strong>of</strong> rinderpest, with comparison tovirus isolation. Res. Vet. Sci. 63:103-106, 1997.Brown, C.C.: Emerging diseases: What veterinarians need toknow. J. Vet. Diagn. Invest. 9:113-117, 1997.Brown, S.A., Crowell, W.A., Brown, C.A., Barsanti, J.A.,Finco, D.R.: Pathophysiology and management <strong>of</strong> progressiverenal disease in dogs. Bri. Vet. J. 154:93-109, 1997.Brown, S., Langford, K., Tarver, S.: Effects <strong>of</strong> certain vasoactiveagents on the long-term pattern <strong>of</strong> blood pressure, heartrate, and motor activity in cats. Am. J. Vet. Res. 58:647-651,1997.Brown, T.P., Garcia, A., Kelley, L.: Spiking mortality <strong>of</strong> turkeypoults: 1. Experimental reproduction in isolation facilities.Avian Dis. 41:604-609, 1997.Brown, T.P., Garcia, A., Sellers, H., Kelley, L.: Spiking mortality<strong>of</strong> turkey poults: 2. Effect <strong>of</strong> six different in vitro disinfectiontechniques on organ homogenates capable <strong>of</strong> reproducingSMT. Avian Dis. 41:906-909, 1997.Browning, R., Jr., Schrick, F.N., Thompson, F.N., Wakefield,Jr., T.: Reproductive hormonal responses to ergotamine andergonovine in cows during the luteal phase <strong>of</strong> the estrouscycle. J. Anim. Sci. 76:1448-1454, 1998.Budsberg, S.C.: Outcome assessment in clinical trials involvingmedical management <strong>of</strong> osteoarthritis in small animals. Vet.Clin. North Am. Small Anim. Pract. 27:815-823, 1997.Buhr, R.J., Cason, J.A., Rowland, G.N.: Feather retentionforce in broilers ante-, peri-, and post-mortem as influencedby carcass orientation, angle <strong>of</strong> extraction, and slaughtermethod. Poult. Sci. 76:1591-1601, 1997.Buhr, R.J., Cason, J.A., Rowland, G.N.: Feather retentionforce in broilers ante-, peri-, and post-mortem as influencedby electrical and carbon dioxide stunning. Poult. Sci.76:1602-1606, 1997.Calvert, C.A., Hall, G., Jacobs, G.J.: Clinical and pathologicalfindings in doberman pinschers with occult cardiomyopathythat died suddenly or developed congestive heart failure. J.Am. Vet. Med. Assoc. 210:505-510, 1997.Calvert, C.A., Jacobs, G.J., Pickus, C.W.: Signalment, survival,and prognostic factors in doberman pinschers withend-stage cardiomyopathy. J. Vet. Intern. Med. 11:323-331,1998.Calvert, C.A., Kraus, M., Jacobs, G.: Possible late potentialsin four dogs with sustained ventricular tachycardia. J. Vet.Intern. Med. 12:96-102, 1998.Chambers, J.N., Selcer, B.A., Sullivan, S.A., Coates, J.R.:Diagnosis <strong>of</strong> lateralized lumbosacral disk herniation withmagnetic resonance imaging. J. Am. Anim. Hosp. Assoc.33:296-299, 1997.Choi, H., Murray, T.F., DeLander, G.E., Schmidt, W.K.,Aldrich, J.V.: Synthesis and opioid activity <strong>of</strong> [D-Pro10]Dynorphin A- (1-11) analogues with N-terminal alkyl substitution.J. Med. Chem. 40:2733-2739, 1997.Clare, A., Medleau, L.: Mosquito bite hypersensitivity in a cat.Vet. Med. 92:728-733, 1997.Clark, J.D., Rager, D.R, Crowell-Davis, S.L., Evans, D.L.:Housing and exercise <strong>of</strong> dogs: Effects on behavior, immunefunction, and cortisol levels. Lab. Anim. Sci. 47:500-510,1997.Clark, T.G., Dickerson, H.W.: Antibody-mediated effects onparasite behavior: Evidence <strong>of</strong> a novel mechanism <strong>of</strong> immunityagainst a parasitic protist. Parasitol. Today 13:477-480,1997.31


Colbert, M.C., Hall, D.G., Kimball, T.R., Witt, S.A., Lorenz,M.I., Kirby, M.L., Hewett, T.E., Klevitsky, R., Robbins,J.: Cardiac compartment-specific overexpression <strong>of</strong> a modifiedretinoic acid receptor produces dilated cardiomyopathyand congestive heart failure in transgenic mice. J. Clin.Invest. 100:1958-1968, 1997.Cornelius, L.M.: Interpreting increased liver enzyme activity indogs. Vet. Med. 92:876-881, 1997.Coy, S.L., Lee, M.D., Sander, J.: Intrastrain-variation <strong>of</strong>lipopolysaccharide <strong>of</strong> Pasteurella multocida in turkeys. Am.J. Vet. Res. 58:755-759, 1997.Creekmore, T.E., Fletcher, W.O., Stallknecht, D.E.:Evaluation <strong>of</strong> two oral baiting systems for wild rodents. J.Wildl. Dis. 34:369-372, 1998.Cross, A.R., Budsberg, S.C., Keefe, T.J.: Kinetic gait analysisassessment <strong>of</strong> meloxicam efficacy in a sodium urate-inducedsynovitis model in dogs. Am. J. Vet. Res. 58:626-631, 1997.Cross, A.R., Chambers, J.N.: Ununited anconeal process <strong>of</strong> thecanine elbow. Compend. Contin. Educ. Pract. Vet. 19:349-361, 1997.Dickerson, H.W., Clark, T.G.: Immune response <strong>of</strong> fishes tociliates. Annu. Rev. Fish Dis. 6:107-120, 1997.Downs, M.O., Miller, M.A., Cross, A.R., Selcer B.A., Abdy,M.J., Watson, E.: Liver lobe torsions and liver abscess in adog. J. Am. Vet. Med. Assoc. 212:678-680, 1998.Dreesen, D.W.: A global review <strong>of</strong> rabies vaccines for humanuse. Vaccine 15:S2-S6, 1997.Dubey, J.P., Rollor, E.A., Smith, K.E., Kwok, O.C.H.,Thulliez, P.: Low seroprevalence <strong>of</strong> Toxoplasma gondii inferal pigs from a remote island lacking cats. J. Parasitol.83:839-841, 1997.Duke, T., Egger, C.M., Ferguson, J.: Cardiopulmonary effects<strong>of</strong> prop<strong>of</strong>ol infusions in llamas. Am. J. Vet. Res. 58:153-156, 1997.Edwards, G.L., White, B.D., He, B., Dean, R.G., Martin,R.J.: Elevated hypothalamic neuropeptide Y levels in ratswith dorsomedial hindbrain lesions. Brain Res. 755:84-90,1997.Ennulat, D., Brown, C.A., Brown, S.A.: Mitogenic effects <strong>of</strong>epidermal growth factor and platelet-derived growth factoron canine and equine mesangial cells in vitro. Am. J. Vet.Res. 58:1308-1313, 1997.Fayrer-Hosken, R.A., Brooks, P., Bertschinger, H.J.,Kirkpatrick, J.F., Turner, J.W., Liu, I.K.M.: Management<strong>of</strong> African elephant populations by immunocontraception.Wildl. Soc. Bull. 25:18-21, 1997.Finco, D.R., Brown, S.A., Barsanti, J.A., Bartges, J.W.,Cooper, T.L.: Reliability <strong>of</strong> using random urine samples for“spot” determination <strong>of</strong> fractional excretion <strong>of</strong> electrolytesin cats. Am. J. Vet. Res. 58:1184-1187, 1997.Finco, D., Brown, S., Barsanti, J., Brown, C., Crowell, W.,Brown, C., Cooper, T.: Effects <strong>of</strong> dietary protein/calorie oncats with induced renal failure. Am. J. Vet. Res. 59:575-582,1998.Fischer, A., Mahaffey, M.B., Oliver, J.E.: Fluoroscopicallyguidedpercutaneous disk aspiration in ten dogs with discospondylitis.J. Vet. Intern. Med. 11:284-287, 1997.Forrester, D.J., Davidson, W.R., Lange, Jr., R.E., Stroud,R.K., Alexander, L.L., Franson, J.C., Haseltine, S.D.,Littell, R.C., Nesbitt. S.A.: Winter mortality <strong>of</strong> commonloons in Florida coastal waters. J. Wildl. Dis. 33:833-847,1997.Foutz, T.L., Rowland, G.N., Evans, M.A.: An avian modelingapproach for analyzing bone loss due to disuse. Trans. Am.Soc. Agric. Eng. 40:1719-1725, 1997.Foutz, T.L., Rowland, G.N., Evans, M.A.: Vibration techniquesto test avian bone in vivo. Trans. Am. Soc. Agric. Eng.40:1727-1731, 1997.Frazier, K., Colvin, B.M., Hullinger, G.A.: Postmortem diagnosis<strong>of</strong> accidental cocaine intoxication in a dog. Vet. Hum.Toxicol. 40:154-155, 1998.Frazier, K., Colvin, B.M., Styer, E.L., Hullinger, G.A.,Garcia, R.: Microcystin toxicosis in cattle due to overgrowth<strong>of</strong> blue-green algae. Vet. Hum. Toxicol. 40:23-24,1998.Garcia, M., Gerchman, I., Meir, R., Jackwood, M.W.,Kleven, S.H., Levisohn, S.: Detection <strong>of</strong> Mycoplasmameleagridis and M. iowae from dead-in-shell turkeyembryos by polymerase chain reaction and culture. AvianPathol. 26:765-778, 1998.Gerwick, W.H., Wise, M.L., Soderstrom, K., Murray, T.F.:Biosynthesis and cannabinoid receptor affinity <strong>of</strong> the noveleicosanoid, conjugated triene anandamide. Adv. Exp. Med.Biol. 407:329-334, 1997.Glaus, T., H<strong>of</strong>fmann-Lehmann, R., Greene, C.E., Glaus, B.,Wolfensberger, C., Lutz, H.: Seroprevalence <strong>of</strong> Bartonellahenselae infection and correlation with disease status in catsin Switzerland. J. Clin. Microbiol. 35:2883-2885, 1997.Gregory, C.R., Harmon, B.G., Latimer, K.S., Hafner, S.,Campagnoli, R.P., McManamon, R.M., Steffens, W.L.:Malignant chromatophoroma in a canebrake rattlesnake(Crotalus horridus atricaudatus). J. Zool. Wildl. Med.28:198-203, 1997.Gregory, C.R., Latimer, K.S., Niagro, F.D., Roberts, A.W.,Campagnoli, R.P., Pesti, D.A., Ritchie, B.W., Lukert,P.D.: Investigations <strong>of</strong> eastern equine encephalomyelitisvirus as the causative agent <strong>of</strong> psittacine proventricular dilationsyndrome. J. Avian Med. Surg. 11:187-193, 1997.Gregory, E., Barnhart, H., Dreesen, D.W., Stern, N.J., Corn,J.L.: Epidemiologic study <strong>of</strong> Campylobacter spp. in broilers:Source, time <strong>of</strong> colonization, and prevalence. Avian Dis.41:890-898, 1997.Hafner, S, Latimer, K.: Cutaneous mast cell tumors with pulmonarymetastasis in a hen. Avian Pathol. 26:657-663, 1997.Hall, D.G., Steffens, W.L., Lassiter, L.L.: Lafora bodies associatedwith neurologic signs in a cat. Vet. Pathol. 35:218-220,1998.Hay, C.W., Chu, Q., Budsberg, S.C., Clayton, M.K., Johnson,K.A.: Synovial fluid interleukin-6, tumor necrosis factor,and nitric oxide values in osteoarthritis secondary to cranialcruciate ligament rupture. Am. J. Vet. Res. 58:1027-1032,1997Hay, W.P., Baskett, A.: Lameness caused by a ganglion in amare. Compend. Contin. Educ. Pract. Vet. 18:1352, 1996.32


Hay, W.P., Baskett, A., Abdy, M.J.: Complete upper airwayobstruction and syncope caused by a subepiglottic cyst in ahorse. Equine Vet. J. 29:75-76, 1997.Hay, W.P., Baskett, A., Gregory, C.R.: Testicular interstitialcell tumor and aplasia <strong>of</strong> the head <strong>of</strong> the epididymis in acryptorchid stallion. Equine Vet. Educ. 9:240-241, 1997..Hay, W.P., Moore, J.N.: Management <strong>of</strong> pain in horses withcolic. Compend. Contin. Educ. Pract. Vet. 19:987-990, 1997.He, B., White, B.D., Edwards, G.L., Martin, R.J.: Longertermfourth ventricular 5-thioglucose increases body fat inthe rat. Proc. Soc. Exp. Biol. Med. 217:168-172, 1998.He, B., White, B.D., Edwards, G.L., Martin, R.J.:Neuropeptide Y antibody attenuates 2-deoxy-D-glucoseinduced feeding in rats. Brain Res. 781:348-350, 1998.Heard, D.J., Ginn, P.E., Neuwirth, L.: Mycobacterium aviumintracellularinfection in a white-faced saki (Pithecia pithecia).J. Zool. Wildl. Med. 28:185-188, 1997.Hnilica, K.A., Angarano, D.W.: Advances in immunology:Role <strong>of</strong> T-helper lymphocyte subsets. Compend. Contin.Educ. Pract. Vet. 19:87-93, 1997.H<strong>of</strong>fman, R.W., Luttrell, M.P., Davidson, W.R., Ley, D.H.:Mycoplasmas in wild turkeys living in association withdomestic fowl. J. Wildl. Dis. 33:526-535, 1997.Howerth, E.W., Stallknecht, D.E., Dorminy, M., Pisell, T.,Clarke, G.R.: Experimental vesicular stomatitis in swine:Effects <strong>of</strong> route <strong>of</strong> inoculation and steroid treatment. J. Vet.Diagn. Invest. 9:136-142, 1997.Hullinger, G.A., Hines II, M.E., Styer, E.L., Frazier, K.S.,Baldwin, C.A.: Pseudocytoplasmic inclusions in tongueepithelium <strong>of</strong> dogs with canine parvovirus-2 infections. J.Vet. Diagn. Invest. 10:108-111, 1998.Hullinger, G.A., Sangster, L., Colvin, B.M., Frazier, K.:Bovine arsenic toxicosis from ingestion <strong>of</strong> ashed copperchrome-arsenatetreated timber. Vet. Hum. Toxicol. 40:147-148, 1998.Idris, A.B., Bounous, D.I., Goodwin, M.A., Brown, J.,Krushinskie, E.A.: Lack <strong>of</strong> correlation between microscopiclesion scores and gross lesion scores in commerciallygrown broilers examined for small intestinal Eimeria spp.coccidiosis. Avian Dis. 41:388-391, 1997.Idris, A.B., Bounous, D.I., Goodwin, M.A., Brown, J.,Krushinskie, E.L.: Quantitative pathology <strong>of</strong> small intestinalcoccidiosis caused by Eimeria maxima in young broilers.Avian Pathol. 26: 731-747, 1997.Jacobs, G.J., Calvert, C.A., Eades, S.: Transmission and interpretation<strong>of</strong> cardiac medical images using a desktop audiovisualteleconferencing system. J. Vet. Med. Educ. 24:56-62,1997.Jacobs, G.J., Calvert, C.A., Kaufman, A.: Neutropenia andthrombocytopenia in three dogs treated with anticonvulsants.J. Am. Vet. Med. Assoc. 212:681-684, 1998.Jacobs, G.J., Cornelius, L., Burrow, M.F., Sherding, R.,Eades, S., Calvert, C.A.: Interpretation <strong>of</strong> Endoscopicimages <strong>of</strong> the gastrointestinal tract following electronictransmission using an interactive videoconferencing system.J. Vet. Med. Educ. 24:52-55, 1997.Jaso-Friedmann, L., Leary, III, J.H., Evans, D.L.: NCCRP-1:A novel receptor protein sequenced from teleost nonspecificcytotoxic cells. Mol. Immunol. 34:955-965, 1997.Jaso-Friedmann, L., Leary, III, J.H., Evans, D.L.: Receptorassociatedphosphorylation following monoclonal antibodyor synthetic peptide binding to nonspecific cytotoxic cells. J.Receptor Signal Transduction Res. 18:67-90, 1998.Johnston, S.A., and Budsberg, S.C.: Nonsteroidal anti-inflammatorydrugs and corticosteroids for the management <strong>of</strong>canine osteoarthritis. Vet. Clin. North Am. Small Anim.Pract. 27:841-862, 1997.Kajon, A.E., Brown, C.C., Spindler, K.R.: Distribution <strong>of</strong>murine adenovirus type 1 in intraperitoneally and intranasallyinfected adult outbred mice. J. Virol. 72:1219-1223, 1998.Kelley, L.C., Mahaffey, E.A., Bounous, D.I., Antczak, D.F.,Brooks, Jr., R.L.: Detection <strong>of</strong> equine and bovine T and Blymphocytes in formalin-fixed paraffin-embedded tissues.Vet. Immunol. Immunopathol. 57:187-200, 1997.Kenny, J.S., Kisaalita, W.S., Rowland, G.N., Thai, C. Foutz,T.: Quantitative study <strong>of</strong> calcium uptake by tumorigenicbone (TE-85) and neuroblastoma x glioma (NG108-15) cellsexposed to extremely-l92-frequency (ELF) electric fields.FEBS Lett. 414:343-348, 1997.Keskintepe, L., Morton, P.C., Smith, S.E., Tucker, M.J.,Simplicio, A.A., Brackett, B.G.: Caprine blastocyst formationfollowing intracytoplasmic sperm injection and definedculture. Zygote 5:261-265, 1997.Keskintepe, L., Simplicio, A.A., Brackett, B.G.: Caprine blastocystdevelopment after in vitro fertilization with spermfrozen in different extenders. Theriogenology 49:1265-1274,1998.Khan, B., Omar, S., Kanyara, J.N., Warren-Perry, M.,Nyalwidhe, J., Peterson, D.S., Wellems, T.E., Kaniaru, S.,Gitonga, J., Mulaa, F.J., Koech, D.K.: Antifolate drugresistance and point mutations in Plasmodium falciparum inKenya. Trans. R. Soc. Trop. Med. Hyg. 91:456-460, 1997.Kirkpatrick, J.F., Turner, Jr., J.W., Liu, I.K.M., Fayrer-Hosken, R.A., Rutberg, A.T.: Case studies in Wildlifeimmunocontraception: Wild and feral equids and whitetaileddeer. Reprod. Fertil. Dev. 9:105-110, 1997.Kleven, S.H.: Changing expectations in the control <strong>of</strong>Mycoplasma gallisepticum. Acta Vet. Hung. 45:299-305,1997.Knutson, K.L., Hoenig, M.: Subnuclear localization <strong>of</strong> proteinkinase C delta in beta cells. Biochem. Mol. Med. 62:50-57,1997.Koos, B.J., Kruger, L., Murray, T.F.: Source <strong>of</strong> extracellularbrain adenosine during hypoxia in fetal sheep. Brain Res.778:439-442, 1997.Koushik, S.V., Sundararaju, B., McGraw, R.A., Philips, R.S.:Cloning, sequence, and expression <strong>of</strong> kynureninase fromPseudomonas fluorescens. Arch. Biochem. Biophys. 344:301-308, 1997.Latimer, K.S., Jameson, P.H., Crowell, W.A., Duncan, J.R.,Currin, K.P.: Disseminated Mycobacterium avium complexinfection in a cat: Presumptive diagnosis by blood smearexamination. Vet. Clin. Pathol. 26:85-98, 1997.Latimer, K.S., Niagro, F.D., Rakich, P.M., Campagnoli, R.P.,Ritchie, B.W., McGee, E.D.: Investigation <strong>of</strong> parrot papillomavirusin cloacal and oral papillomas <strong>of</strong> psittacine birds.Vet. Clin. Pathol. 26:158-163, 1997.33


34Latimer, K.S., Niagro, F.D., Williams, O.C., Ramis, A.,Goodwin, M.A., Ritchie, B.W., Campagnoli, R.P.:Diagnosis <strong>of</strong> avian adenovirus infections using DNA in situhybridization. Avian Dis. 41:773-782, 1997.Lew, L.J., Fowler, J.D., Egger, C.M., Thompson, D.J., Rosin,M.W., Pharr, J.W.: Deep hypothermic low flow cardiopulmonarybypass in small dogs. Vet. Surg. 26:281-289, 1997.Lewis, D.D., Stubbs, W.P., Neuwirth, L., Bertrand, S.G.,Parker, R.B., Stallings, J.T., Murphy, S.: Results <strong>of</strong>screw/wire/polymethylmethacrylate composite fixation foracetabular fracture repair in fourteen dogs. Vet. Surg.26:223-234, 1997.Linhart, S.B., Baer, G.M., Balderas Torres, J.M., Engeman,R.M., Collins, E.F., Meslin, F.X., Schumacher, C.L.,Taweel (El-), A-H, Wlodkowski, J.C.: Acceptance <strong>of</strong> candidatebaits by domestic dogs for delivery <strong>of</strong> oral rabies vaccines.Onderstepoort J. Vet. Res. 64:115-124, 1997.Linhart, S.B., King, R., Zamir, S., Naveh, U., Davidson, M.,Perl, S.: Oral rabies vaccination <strong>of</strong> red foxes and goldenjackals in Israel: Preliminary bait evaluation. Rev. Sci. Tech.Off. Int. Epizoot. 16:874-880, 1997.Little, S.E., Carmichael, K.P., Rakich, P.M.: Trombidiosisinduceddermatitis in white-tailed deer (Odocoileus virginianus).Vet. Pathol. 34:350-352, 1997.Little, S.E., Davidson, W.R., Howerth, E.H., Rakich, P.M.,Nettles, V.F.: Diseases diagnosed in red foxes (Vulpesvulpes) from the Southeastern United States. J. Wildl. Dis.34:620-624, 1998.Little, S.E., Davidson, W.R., Rakich, P.M., Nixon, T.L.,Bounous, D.I., Nettles, V.F.: Responses <strong>of</strong> red foxes(Vulpes vulpes) to first and second infestation withSarcoptes scabiei. J. Wildl. Dis. 34:625-628, 1998.Lockhart, J.M., Davidson, W.R., Stallknecht, D.E., Dawson,J.E.: Lack <strong>of</strong> seroreactivity to Ehrlichia chaffeensis amongrodent populations. J. Wildl. Dis. 34:392-396, 1998.Lockhart, J.M., Davidson, W.R., Stallknecht, D.E., Dawson,J.E., Howerth, E.W.: Isolation <strong>of</strong> Ehrlichia chaffeensisfrom wild white-tailed deer (Odocoileus virginianus) confirmstheir role as natural reservoir hosts. J. Clin. Microbiol.35:1681-1686, 1997.Lockhart, J.M., Davidson, W.R., Stallknecht, D.E., Dawson,J.E., Little, S.E.: Natural history <strong>of</strong> Ehrlichia chaffeensis(Rickettsiales: Ehrlichieae) in the Piedmont physiographicprovince <strong>of</strong> <strong>Georgia</strong>. J. Parasitol. 83:887-894, 1997.Lowder, M.Q.: Who is teaching equine dentistry? Compend.Contin. Educ. Pract. Vet. 19:624-626, 1997.Luo, Y., Glisson, J.R., Jackwood, M.W.: Cloning and characterization<strong>of</strong> the major outer membrane protein gene (ompH)<strong>of</strong> Pasteurella multocida X-73. J. Bacteriol. 179: 7856-7864,1997.Luttrell, M.P., Stallknecht, D.E., Fischer, J.R., Sewell, C.T.,Kleven, S.H.: Natural Mycoplasma gallisepticum infectionin a captive flock <strong>of</strong> house finches. J. Wildl. Dis. 34:289-296, 1998.Marsh, T.E., Fluke, D.K., Villegas, P.: Efficacy <strong>of</strong>INOVOJECT ® egg injection system for delivering Marek’sdisease vaccine under hatchery conditions. Avian Dis.41:452-454, 1997.Martin, C.L., Stiles, J., Willis, M.: Feline colobomatous syndrome.Vet. Comp. Ophthalmol. 7:39-43, 1997.Maurer, J.J., Brown, T.P., Steffens, W.L., Thayer, S.G.: Theoccurrence <strong>of</strong> ambient temperature-regulated adhesins, curli,and the temperature-sensitive hemagglutinin TSH amongavian Escherichia coli. Avian Dis. 42:106-118, 1998.Medders, W.M., Wooley, R.E., Shotts, E.B., Gibbs, P.S.:Mutation rates <strong>of</strong> avian micr<strong>of</strong>lora when pressured with fluoroquinolones.Avian Dis. 42:146-153, 1998.Miguel, B., Wang, C., Maslin, W.R., Keirs, R.W., Glisson,J.R.: Subacute to chronic fowl cholera in a flock <strong>of</strong> Pharaohbreeder quail. Avian Dis. 42:204-208, 1998.Miller, C.C., Selcer, B.A., Williamson, L., Mahaffey, E.A.:Surgical treatment <strong>of</strong> a septic dentigerous cyst in a goat. Vet.Rec. 140:528-530, 1997.Moore, K.M., Jackwood, M.W, Hilt, D.A., Brown, T.P.:Identification <strong>of</strong> amino acids involved in a serotype and neutralizationspecific epitope within the S1 subunit <strong>of</strong> avianinfectious bronchitis virus. Arch.Virol. 142:2249-2256,1997.Mueller, P.O.E., Harmon, B.G., Eades, S.C., Moore, J.N.:Contribution <strong>of</strong> neutrophils to endotoxin-induced mucosaldysfunction in the feline jejunum. J. Endotoxin Res. 4:25-31, 1997.Neuwirth, L., Collins, B., Claderwood-Mays, M., Tran, T.:Adrenal ultrsonography correlated with histopathology inferrets. Vet. Radiol. Ultrasound 38:69-74, 1997.Niezgoda, M. Briggs, D.J., Shaddock J., Dreesen, D.W.,Rupprecht, C.E.: Pathogenesis <strong>of</strong> experimentally-inducedrabies in domestic ferrets. Am. J. Vet. Res. 58:1327-1331,1997.Novak, R., Ragland, W.L.: In situ hybridization for detection <strong>of</strong>chicken anemia virus in peripheral blood smears. Mol. Cell.Probes 11:135-141, 1997.Nussbaum, K.E., Bounous, D.I., Welles, E.G.: In support <strong>of</strong>changes in veterinary curricula. J. Am. Vet. Med. Assoc.211:27-28, 1997.Otto, C.M., Niagro, F., McGraw, R.A., Rawlings, C.A.:Production <strong>of</strong> polyclonal antibodies to feline tumor necrosisfactor. Clin. Diagn. Lab. Immunol. 4:487-490, 1997.Parks, A.H.: Wounds <strong>of</strong> the equine foot: Principles <strong>of</strong> healingand treatment. Equine Vet. Educ. 9:317-327, 1997.Pilkington, P., Brown, T.P., Villegas, P., McMurray, B., Page,R.K., Rowland, G.N., Thayer, S.G.: Adenovirus-inducedinclusion body hepatitis in four-day-old broiler breeders.Avian Dis. 41:472-474, 1997.Plaza, H., Whelchel, T.R., Garczynski, S.F., Howerth, E.W.,Gherardini, F.C.: Purified outer membranes <strong>of</strong> Serpulinahyodysenteriae contain cholesterol. J. Bacteriol. 179:5414-5421, 1997.Puette, M., Latimer, K.S.: Acute granulocytic leukemia in aslaughter goat. J. Vet. Diagn. Invest. 9:318-319, 1997.Qiu, H., Jun, H.W., Dzimianski, M., McCall, J.: Reducedtransdermal absorption <strong>of</strong> N,N-diethyl-m-toluamide from anew topical insect repellent formulation. Pharm. Dev.Technol. 2:33-42, 1997.Quist, C.F., Dutton, D.M., Schneider, D., Prestwood, A.K.:Gastrointestinal ulceration and pulmonary aspergillosis in allama treated for parelaphostrongylosis. J. Am. Vet. Med.Assoc. 212:1638-1642, 1998.


Quist, C.F., Howerth, E.W., Bounous, D.I., Stallknecht, D.E.:Cell-mediated immune response and IL-2 production inwhite-tailed deer experimentally infected with hemorrhagicdisease viruses. Vet. Immunol. Immunopathol. 56:283-297,1997.Quist, C.F., Howerth, E.W., Stallknecht, D.E., Brown, J.,Pisell, T., Nettles, V.F.: Host defense responses associatedwith experimental hemorrhagic disease in white-tailed deer.J. Wildl. Dis. 33:584-599, 1997.Ragland, W.L., Mazija, H., Kleven, S.H., Elfaki, M.G.,Rukavina, V.: Immunization <strong>of</strong> day-old chickens usingkilled Mycoplasma gallisepticum bacterin with iota carrageenanadjuvant. Prax. Veterinaria 44:145-147, 1996.Ramis, A., Latimer, K.S., Gibert, X., Campagnoli, R.: A concurrentoutbreak <strong>of</strong> psittacine beak and feather disease, andavian polyomavirus infection in budgerigars (Melopsittacusundulatus). Avian Pathol. 27:43-50, 1998.Rawlings, C.A., Mahaffey, M.B., Barsanti, J.A., Quandt, J.E.,Oliver, Jr., J.E., Crowell, W.A., Downs, M.O., Stampley,A.R., Allen, S.W.: Use <strong>of</strong> partial prostatectomy for treatment<strong>of</strong> prostatic abscesses and cysts in dogs. J. Am. Vet.Med. Assoc. 211:868-872, 1997.Rawlings, C.A., Roberts, R.E., Jacobs, G., McCall, J., Brown,J., Burrow, M.: Comparison <strong>of</strong> thoracic radiographs withimages transmitted via advanced telecommunications equipment.J. Am.Vet. Med. Assoc. 211:1245-1248, 1997.Ritchie, B., Latimer, K., Leonard, J., Pesti, D., Campagnoli,R., Lukert, P.: Safety, immunogenicity and efficacy <strong>of</strong> aninactivated avian polyomavirus vaccine. Am. J. Vet. Res.59:143-148, 1998.Ritchie, B.W., Vaughn, S.B., St. Leger, J., Rich, G.A.,Rupiper, D.J., Forgey, G., Greenacre, C.B., Latimer,K.S., Pesti, D., Campagnoli, R., Lukert, P.D.: Use <strong>of</strong> aninactivated virus vaccine to control polyomavirus outbreaksin nine flocks <strong>of</strong> psittacine birds. J. Am. Vet. Med. Assoc.212:685-690, 1998.Robinson, C.P., Bounous, D.I., Alford, C.E., Nguyen, K.H.T.,Nani, J.M., Peck, A.B., Humphreys-Beher, M.G.: PSPexpression in murine lacrimal glands and function as a bacteriabinding protein in exocrine secretions. Am. J. Physiol.35:863-871, 1997.Robinson, C.P., Cornelius, J., Bounous, D.I., Peck, A.B.,Humphreys-Beher, M.G.: Characterization <strong>of</strong> the changinglymphocyte populations and cytokine expression in theexocrine tissues <strong>of</strong> autoimmune NOD mice. Autoimmunity27:29-44, 1998.Robinson, C.P., Yamachika, S., Bounous, D.I., Brayer, J.,Jonsson, R., Holmdahl, R., Peck, A.B., Humphreys-Beher, M.G.: A novel NOD-derived murine model for primarySjogren’s syndrome. Arthritis Rheum. 41:150-156,1998.Saito, E.K., Little, S.E.: Filarial dermatitis in a striped skunk.J.Wildl. Dis. 33:873-876, 1997.Sander, J.E., Jackwood, M.W., Rowland, G.N.: Protection bya commercial Arkansas-type Infectious Bronchitis Virusvaccine against a field isolate <strong>of</strong> the same serotype. AvianDis. 41:964-967, 1997.Sander, J.E., Resurreccion, R.S., Waltman, W.D., McMurray,B.L.: Pasteurella challenge and ELISA serology evaluation<strong>of</strong> broiler breeders vaccinated with live cholera vaccine.Avian Dis. 42:190-193, 1998.Sander, J.E., Savage, S.I., Rowland, G.N.: Sodium sesquicarbonatetoxicity in broiler chickens. Avian Dis. 42:215-218,1998.Sander, J.E., Steffens, W.L.: Transmission electron microscopicdemonstration <strong>of</strong> abnormalities on the tracheal cilia <strong>of</strong>chicks exposed to formaldehyde during hatching. Avian Dis.41:977-980, 1997.Sander, J., Thayer, S.G.: Research Note—Evaluation <strong>of</strong> ELISAtiters to infectious laryngotracheitis. Avian Dis. 41:429-432,1997.Sander, J., Williams, R., Novak, R., Ragland, W.: CaseReport—In situ hybridization on blood smears for diagnosis<strong>of</strong> chicken anemia virus in broiler breeder flocks. Avian Dis.41:988-992, 1997.Segalés, J., Sitjar, M., Domingo, M., Dee, S., Del Pozo, M.,Noval, R., Sacristan, C., De las Heras, A., Ferro, A.,Latimer, K.S.: First report <strong>of</strong> post-weaning multisystemicwasting syndrome in Spain. Vet. Rec. 141:600-601, 1997.Sharma, R.P., Dugyala, R.R., Voss, K.A.: Demonstration <strong>of</strong> insitu apoptosis in mouse liver and kidney after short-termrepeated exposure to fumonisin B1. J. Comp. Pathol.117:371-381, 1997.Shin, S. S., Elvinger, F., Prestwood, A.K., Cole, Jr., J.R.:Exposure <strong>of</strong> swine to Trichinella spiralis antigen as determinedby consecutive ELISAs and Western blot. J. Parasitol.83:430-433, 1997.Smith, A.W., Berry, E.S., Skilling, D.E., Barlough, J.E., Poet,S.E., Berke, T., Mead, J., Matson, D.O.: In vitro isolationand characterization <strong>of</strong> a calicivirus causing a vesicular disease<strong>of</strong> the hands and feet. Clin. Infect. Dis. 26:434-439,1998.Smith, J.D., Newell, S.M., Budsberg, S.C., Bennett, R.A.:Incidence <strong>of</strong> contralateral versus ipsilateral neurologicalsigns associated with lateralized Hansen type I intervertebraldisc extrusion. J. Small Anim. Pract. 38:495-497, 1997.Smith, K.E., Quist, C.F., Crum, J.M.: Clinical illness in a wildturkey with Laminosioptes cysticola infestation <strong>of</strong> the visceraand peripheral nerves. Avian Dis. 41:484-489, 1997.Soderstrom, K., Choi, H., Aldrich, J.V., Murray, T.F.: N-alkylatedderivatives <strong>of</strong> [D-Pro10] Dynorphin A (1-11) are highaffinity partial agonists at the cloned rat κ-opioid receptor.Eur. J. Pharmacol. 338:191-197, 1997.Soderstrom, K., Murray, T.F., Yoo, H.D., Ketchum, S.,Milligan, K., Gerwick, W., Ortega, M.J., Salva, J.:Discovery <strong>of</strong> novel cannabinoid receptor ligands fromdiverse marine organisms. Adv. Exp. Med. Biol. 433:73-77,1997.Stallknecht, D.E., Howerth, E.W., Kellogg, M.L., Quist, C.F.,Pisell, T.: In vitro replication <strong>of</strong> epizootic hemorrhagic diseaseand bluetongue viruses in white-tailed deer peripheralblood mononuclear cells and virus-cell association during invivo infections. J. Wildl Dis. 33:574-583, 1997.Stern, N.J., Myszewski, M.A., Barnhart, H.M., Dreesen,D.W.: Flagellin A gene restriction length polymorphism patterns<strong>of</strong> Campylobacter spp. isolates from broiler productionsources. Avian. Dis. 41:899-905, 1997.Stiles, J., Didier, E., Ritchie, B., Greenacre, C., Willis, M.,Martin, C.: Encephalitozoon cuniculi in the lens <strong>of</strong> a rabbitwith phacoclastic uveitis: Confirmation and treatment. Vet.Comp. Ophthalmol. 7:233-238, 1998.35


Stiles, J., McDermott, M., Bigsby, D., Willis, M., Martin, C.,Roberts, W., Greene, C.: Use <strong>of</strong> nested polymerase chainreaction to identify feline herpesvirus in ocular tissue fromclinically normal cats and cats with corneal sequestra orconjunctivitis. Am. J. Vet. Res. 58:338-342, 1997.Stiles, J., McDermott, M., Willis, M., Roberts, W., Greene,C.: Comparison <strong>of</strong> Nested polymerase chain reaction, virusisolation, and fluorescent antibody testing for identifyingfeline herpesvirus in cats with conjunctivitis. Am. J. Vet.Res. 58:804-807, 1997.Swayne, D.E., Perdue, M.L., García, M., Rivera-Cruz, E.,Brugh, M.: Pathogenicity and diagnosis <strong>of</strong> H5N2 Mexicanavian influenza viruses in chickens. Avian Dis. 41:335-346,1997.Timchalk, C., Finco, D.R., Quast, J.F.: Evaluation <strong>of</strong> renalfunction in Rhesus monkeys and comparison to Beagle dogsfollowing oral administration <strong>of</strong> the organic acid Tricyclopyr(3,5,6-trichloro-2-pyridinyloxyacetic acid). Fundam. Appl.Pharmacol. 36:47-53, 1997.Topper, M.J., Prasse, K.W.: Analysis <strong>of</strong> coagulation proteins asacute-phase reactants in horses with colic. Am. J. Vet. Res.59:542-545, 1998.Topper, M.J., Prasse, K.W.: Chromogenic assays for equinecoagulation factors VII, VIII: C, IX, and X, and C1-esteraseinhibitor. Am. J. Vet. Res. 59:538-541, 1998.Voges, A.K., Bertrand, S., Hill, R.C., Neuwirth, L. Schaer,M.: True diaphragmatic hernia in a cat. Vet. Radiol.Ultrasound 38:116-119, 1997.Wang, T., Edwards, G.L.: Differential effects <strong>of</strong> lesion size oningestive behavior in rats. Am. J. Physiol. 273:R1299-R1308, 1997.Weisman, Z., Evans, D.L., Jaso-Friedmann, L.: Human IL-2Activated adherent NK cells recognize a conserved antigenfound on tumor cells and protozoan parasites. J. Nat.Immun. 15:269-284, 1997.White, L.M., Warren, R.J., Evans, D.L.: Theory and practice<strong>of</strong> immunocontraception in wild mammals. Wildl. Soc. Bull.25:20-30, 1997.Whittaker, C.J.G., Schumacher, J., Bennett, R.A., Neuwirth,L., Gelatt, K.N.: Orbital varix in a green iguana (Iguanaiguana). Vet. Comp. Ophthalmol. 7:101-103, 1997.Willis, M., Bounous, D., Hirsh, S., Kaswan, R., Stiles, J.,Martin, C., Rakich, P., Roberts, W.: Conjunctival brushcytology: Evaluation if a new cytological collection techniquein dogs and cats with a comparison to conjunctivalscraping. Vet. Comp. Ophthalmol. 7:74-81, 1997.Willis, M., Martin, C.L., Stiles, J., Chaffin, K.: Acute, transientsialoadenomegaly in two cats following topical administration<strong>of</strong> tropicamide. Vet. Comp. Ophthalmol. 7:206-208,1997.Wooley, R.E., Gibbs, P.S., Brown, T.P., Glisson, J.R., Steffens,W.L., Maurer, J.J.: Colonization <strong>of</strong> the chicken trachea byan avirulent avian Escherichia coli transformed with plasmidpHK11. Avian Dis. 42:194-198, 1998.Yao, C., McGraw, R.A., Prestwood, A.K.: A complementaryDNA encoding an antigen from Trichinella spiralis musclelarvae and its analog from Trichinella T5 <strong>of</strong> bobcat origin:Sequence, cloning, and expression. Int. J. Parasitol. 27:425-430, 1997.Young, L., Cornish, T., Little, S.: Concomitant verminous andmycotic pneumonia in a blue jay from <strong>Georgia</strong>. J. Wildl.Dis. 34:600-611, 1998.Zhang, G., Murray, T.F., Grandy, D.K.: Orphanin FQ, theendogenous agonist for the opioid-like orphan receptorLC132, has an inhibitory effect on guinea-pig ileum andmouse vas deferens. Brain Res. 772:102-106, 1997.Zhao, T., Doyle, M.P., Harmon, B.G., Brown, C.A., Mueller,P.O.E, Parks, A.H.: Reduction <strong>of</strong> carriage <strong>of</strong> enterohemorrhagicEscherichia coli O157:H7 in cattle by inoculationwith probiotic bacteria. J. Clin. Microbiol. 36:641-647,1998.36

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!